| 1 |
Triamcinolone Acetonide Cream 0.1% w/w
|
|
548 KB |
| 2 |
Selpercatinib
|
|
653 KB |
| 3 |
Finerenone 10 mg and 20 mg
|
|
2588 KB |
| 4 |
Mino-Lok Therapy (MLT
|
|
649 KB |
| 5 |
AB001 400mg Tablets
|
|
2052 KB |
| 6 |
ZY19489
|
|
2030 KB |
| 7 |
AZD1222 Vaccine
|
|
674 KB |
| 8 |
SRP-4045 and SRP-4053
|
|
659 KB |
| 9 |
PNB001
|
|
2240 KB |
| 10 |
Eteplirsen
|
|
667 KB |
| 11 |
Clotrimazole Vaginal Film 50 mg
|
|
437 KB |
| 12 |
Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate (ER) + Telmisartan IP + Amlodipine Besilate IP eq. to Amlodipine Film Coated Bilayered tablet (Phase III)
|
|
414 KB |
| 13 |
LNP023gc
|
|
659 KB |
| 14 |
Thymosin Alpha 1 for injection 1.6 mg
|
|
411 KB |
| 15 |
LNP023
|
|
659 KB |
| 16 |
Ramatroban tablets 75 mg
|
|
1855 KB |
| 17 |
Dupilumabr
|
|
792 KB |
| 18 |
Sovateltide
|
|
2118 KB |
| 19 |
Vildagliptin (as sustained release form) + Metformin Hydrochloride As sustained release formIP uncoated bilayered tablets (Phase III
|
|
182 KB |
| 20 |
Pantoprazole Dual Release Gastro-Resistant Tablet 80 mg
|
|
372 KB |
| 21 |
Inhaled Itracoanzole Dry Powder for inhalation 10 mg capsule (PUR 1900)
|
|
471 KB |
| 22 |
Glycopyrrolate IP + Formoterol Fumarate dehydrate IP eq. to Formoterol Fumarate + Budesonide IP Per actuation deliver (Phase IV)
|
|
184 KB |
| 23 |
ES16001
|
|
645 KB |
| 24 |
inclisiran
|
|
645 KB |
| 25 |
Telmisartan IP + Bisoprolol Fumarate IP tablets (Phase III)
|
|
256 KB |
| 26 |
101-PGC-005
|
|
2107 KB |
| 27 |
Azelastine Hydrohloride 1 mg/ml Nasal Spray
|
|
423 KB |
| 28 |
Guselkumab
|
|
788 KB |
| 29 |
NRC-1111
|
|
2198 KB |
| 30 |
remibrutinib versus teriflunomide
|
|
661 KB |
| 31 |
Fosfomycin Trometamol Powder 3 gm
|
|
477 KB |
| 32 |
HRF-10071, Darunavir and Ritonavir
|
|
2004 KB |
| 33 |
Mirabegron (ER) + Solifenacin Succinate IP film coated bilayered tablet (Phase IV
|
|
186 KB |
| 34 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Linagliptin film coated tablet (Phase III)
|
|
283 KB |
| 35 |
Vildagliptin IP (as sustained release)Pioglitazone Hydrochloride IP eq. to Pioglitazone tablets (Phase III)
|
|
229 KB |
| 36 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Sitagliptin Phosphate monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IP film coated tabletPhase III)
|
|
195 KB |
| 37 |
Vericiguat therapy
|
|
2443 KB |
| 38 |
Dapagliflozin IP +Metformin Hydrochloride IP (as sustained release) + Sitagliptin Phosphate Monohydrate IP bilayered tablet (Phase III)
|
|
192 KB |
| 39 |
Metformin Hydrochloride IP (SR) + Pioglitazone Hydrochloride IP + Sitagliptin Phosphate IP eq. to Sitagliptin film coated bilayered tablet (Phase III)
|
|
206 KB |
| 40 |
Paclitaxel-Carboplatin-Oregovomab)
|
|
673 KB |
| 41 |
Dupilumabn
|
|
691 KB |
| 42 |
Ondansetron Extended Relese Injectable Supension 100mg/ml
|
|
400 KB |
| 43 |
Vildagliptin + Pioglitazone Hydrochloride IP eq. to Pioglitazone uncoated tabletsPhase III)
|
|
211 KB |
| 44 |
Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate (as extended release) + Amlodipine Besilate IP eq. to Amlodipine + Chlorthalidone IP film coated bilayered tablets (Phase III)
|
|
206 KB |
| 45 |
remibrutinib versus teriflunomidegc
|
|
654 KB |
| 46 |
Trelagliptin
|
|
2481 KB |
| 47 |
HRF-10071 and Dolutegravir
|
|
2256 KB |
| 48 |
Tirzepatide
|
|
664 KB |
| 49 |
Durvalumabgct
|
|
668 KB |
| 50 |
Oral AUR105
|
|
2312 KB |
| 51 |
Capivasertib + Docetaxel
|
|
657 KB |
| 52 |
Durvalumab plus Domvanalimab (AB154
|
|
684 KB |
| 53 |
Cefepime Zidebactam vs. Meropenem
|
|
661 KB |
| 54 |
Tremelimumab ± Lenvatinib
|
|
676 KB |
| 55 |
IcoSema and once weekly insulin icodec
|
|
687 KB |
| 56 |
Linagliptin + Dapagliflozin tablets (Phase III)
|
|
260 KB |
| 57 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin film coated tablets (Phase III)
|
|
192 KB |
| 58 |
Bucillamine tablets 100mg
|
|
2592 KB |
| 59 |
Triamcinolone Hexacetonide Injectable Suspension 20 mg/ml
|
|
2426 KB |
| 60 |
Vildagliptin (SR) + Pioglitazone Hydrochloride IP film coated bilayered tablets (Phase III)
|
|
206 KB |
| 61 |
Tofacitinib Ointment 2%
|
|
491 KB |
| 62 |
Teriperatide Injection solution for injection in a pre-filled pen 600mcg/2.4ml (Synthetic Origin)
|
|
538 KB |
| 63 |
Dapagliflozin Propanedilol Monohydrate eq. to Dapagliflozin + Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin Film Coated Tablets (Phase III)
|
|
294 KB |
| 64 |
EMPAgliflozin
|
|
800 KB |
| 65 |
Pregabalin IP (As Prolonged Release) + Etoricoxib IP film coated bilayered tablets (Phase IV)
|
|
309 KB |
| 66 |
Lyka Labs
|
|
426 KB |
| 67 |
Metformin Hydrochloride IP (as sustained release) + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin film coated bilayered tablets (Phase III)
|
|
291 KB |
| 68 |
Glycopyrrolate IP eq. to Glycopyrronium _+ Formoterol Fumarate Dihydrate IP eq. to Formoterol Fumarate + Budesonide inhalation powder (Phase IV)
|
|
319 KB |
| 69 |
HRF-10071, Tenofovir, Dolutegravir
|
|
2031 KB |
| 70 |
Ajanta Pharma
|
|
365 KB |
| 71 |
f GSK S. aureus candidate vaccine
|
|
673 KB |
| 72 |
CSJ117
|
|
651 KB |
| 73 |
Glimepiride IP + Metformin Hydrochloride IP + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin (Phase II
|
|
275 KB |
| 74 |
Nor-ursodeoxycholic acid
|
|
2242 KB |
| 75 |
Sitagliptin Phosphate IP eq. to Sitagliptin + Dapagliflozin tablets (Phase III)
|
|
293 KB |
| 76 |
HRF-10071, Ripivirine
|
|
2165 KB |
| 77 |
AUR103 Calciumin
|
|
2392 KB |
| 78 |
HRF-10071, Tenofovir alafenamide and Emtricitabin
|
|
2148 KB |
| 79 |
MS/ Veeda
|
|
2124 KB |
| 80 |
HRF-10071, Tenofovir alafenamide and Ripivirine
|
|
2175 KB |
| 81 |
Chlorthalidone IP + Efonidipine Hydrochloride Ethanolate IP tablets (Phase III)
|
|
266 KB |
| 82 |
Paltusotine
|
|
674 KB |
| 83 |
Glimepiride IP + Metformin Hydrochloride IP + Sitagliptin Phosphate Monohydrate IP Tablets (Phase III)
|
|
319 KB |
| 84 |
Dapagliflozin + Teneligliptin Hydrobromide Hydrate IP eq. to Dapagliflozin (Phase III)
|
|
248 KB |
| 85 |
Elobixibat
|
|
2497 KB |
| 86 |
concizumab prophylaxis
|
|
653 KB |
| 87 |
LL-BMT1
|
|
652 KB |
| 88 |
SCO-120
|
|
487 KB |
| 89 |
Brinzolamide IP + Timolol Maleate IP eq. to Timolol + Potassium Sorbate IP (as preservative) Ophthalmic suspension (Phase IV)
|
|
308 KB |
| 90 |
Silodosin + Tdalafil IP hard gelatin capsule (Phase III)
|
|
277 KB |
| 91 |
Fosravuconazole capsules
|
|
2338 KB |
| 92 |
Linaclotide Capsules
|
|
2258 KB |
| 93 |
Umifenovir Tablet
|
|
2240 KB |
| 94 |
Atrasentan
|
|
662 KB |
| 95 |
Tislelizuma
|
|
673 KB |
| 96 |
IRINOTECAN AND TEMOZOLOMIDE
|
|
653 KB |
| 97 |
TOPOTECAN AND CYCLOPHOSPHAMIDE
|
|
653 KB |
| 98 |
Savolitinib plus Durvalumab
|
|
806 KB |
| 99 |
MYL-1701P
|
|
655 KB |
| 100 |
Naftifine hydrochloride cream 2% b
|
|
2544 KB |
| 101 |
LY3484356
|
|
669 KB |
| 102 |
ASLAN004
|
|
672 KB |
| 103 |
Efonidipine Hydrochloride Ethanolate IP + Telmisartan IP film coated tablets (Phase III)
|
|
290 KB |
| 104 |
osimertinib
|
|
707 KB |
| 105 |
Polmacoxib Capsules
|
|
3066 KB |
| 106 |
Semaglutide on functional capacity
|
|
652 KB |
| 107 |
AUR-101
|
|
2296 KB |
| 108 |
GRC 54276
|
|
2658 KB |
| 109 |
Sitagliptin Phosphate monohydrate eq. to Sitagliptin IP + Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin film coated tablets (Phase III)
|
|
366 KB |
| 110 |
TK-90M/s. SiRO
|
|
627 KB |
| 111 |
Metformin Hydrochloride IP (as sustained release) + Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin + Dapagliflozin tablets (Phase III
|
|
306 KB |
| 112 |
Belantamab Mafodotin (GSK2857916)
|
|
649 KB |
| 113 |
TK-90
|
|
626 KB |
| 114 |
Sodium Hyaluronate BP + Chontroitin Sulfate Sodium BP + Poloxamer IP per 10ml oral liquid (Phase IV)
|
|
311 KB |
| 115 |
Metformin Hydrochloride IP (as extended release) + Dapagliflozin + Teneligliptin hydrobromide Hydrate IP eq. to Teneligliptin film coated bilayered tablets (Phase III)
|
|
317 KB |
| 116 |
SAR442168 to placebo
|
|
671 KB |
| 117 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin film coated tablets (Phase III
|
|
326 KB |
| 118 |
NUCALA
|
|
2527 KB |
| 119 |
Sun Pharma
|
|
416 KB |
| 120 |
Dapagliflozin Propanediol eq. to Dapagliflozin + Sitagliptin Phosphate monohydrate IP eq. to to Sitagliptin film coated tablet (Phase III)
|
|
320 KB |
| 121 |
Vildagliptin (as sustained release) + Pioglitazone Hydrochloride eq. to Pioglitazone IP uncoated bilayered tablets (Phase III)
|
|
304 KB |
| 122 |
CRIZOTINIB
|
|
422 KB |
| 123 |
Vildagliptin (as sustained release) + Dapagliflozin (100mg+5mg & 100mg + 10mg) tablets (Phase III)M/s. Ravenbhel Healthcare Pvt. Ltd
|
|
281 KB |
| 124 |
Sun Pharma
|
|
505 KB |
| 125 |
Chlorpheniramine Maleate IP + Noscapine IP per 5ml oral liquid (Phase III)
|
|
392 KB |
| 126 |
Revefenacin
|
|
2350 KB |
| 127 |
Vildagliptin (as sustained release form) + Metformin Hydrochloride (as sustained release form) IP uncoated bilayered tablets (Phase III)
|
|
290 KB |
| 128 |
Remogliflozin Etabonate + Vildagliptin + Metformin Hydrochloride IP Film coated tablet (Phase IV)
|
|
329 KB |
| 129 |
TOFACITINIB
|
|
663 KB |
| 130 |
Tamsulosin Hydrochloride IP (as prolonged release pellets) + Tadalafil IP (as film coated tablet) capsules (Phase IV)
|
|
352 KB |
| 131 |
Teneligliptin IP + Dapagliflozin tablets (Phase III)
|
|
271 KB |
| 132 |
AT-752
|
|
787 KB |
| 133 |
ELRANATAMAB
|
|
665 KB |
| 134 |
dupilumab
|
|
667 KB |
| 135 |
Nitazoxanide Tablets 500 mg
|
|
656 KB |
| 136 |
Lifeviro treat inhalation
|
|
2497 KB |
| 137 |
Atropine Sulphate Ophthalmic Solution 0.05% w/v0.05 % w/v Ophthalmic Solution
|
|
466 KB |
| 138 |
Acalabrutinib1
|
|
665 KB |
| 139 |
Metoprolol IP + Chlorthalidone IP + Cilnidipine IP tablets (Phase III)
|
|
276 KB |
| 140 |
SAR442168
|
|
849 KB |
| 141 |
Abrocitinib
|
|
30383KB |
| 142 |
Imeglimin tabletsv
|
|
2952 KB |
| 143 |
Intraversial SN-38 Lipid Suspension
|
|
2587 KB |
| 144 |
Picrorhiza kurroa
|
|
2654 KB |
| 145 |
Amlodipine Besylate IP eq. to Amlodipine + Azilsartan Kamedoxomil eq. to Azilsartan Medoxomil tablets (Phase III)
|
|
316 KB |
| 146 |
Tofacetinib Gel 2%
|
|
425 KB |
| 147 |
Dapagliflozin + Sitagliptin film coated tablet (Phase III)M/s. Glenmark Pharmaceuticals Ltd
|
|
286 KB |
| 148 |
Tranexamic Acid Spray 10% w/v Acid Spray 10% w/v Acid Spray 10% w/v
|
|
394 KB |
| 149 |
Dapagliflozin + Sitagliptin film coated tablet (Phase IIIg
|
|
286 KB |
| 150 |
Imeglimin tablets
|
|
2592 KB |
| 151 |
Dapagliflozin + Metformin Hydrochloride IP + Vildagliptin film coated tablets (Phase III)
|
|
297 KB |
| 152 |
Naftifine hydrochloride cream 2%
|
|
2682 KB |
| 153 |
Pimavenserin Capsules
|
|
2375 KB |
| 154 |
Bioactive concentrate from small marine fish + water for injection (WFI) solution for injection (Phase III)
|
|
296 KB |
| 155 |
Vildagliptin SR + Dapagliflozin + film coated bilayered tablets (Phase III)
|
|
286 KB |
| 156 |
Ferric Pyrophosphate citrate
|
|
2622 KB |
| 157 |
Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5
|
|
659 KB |
| 158 |
tocilizumab
|
|
653 KB |
| 159 |
Vildagliptin + Dapagliflozin + Metformin hydrochloride IP tablets (Phase III)
|
|
341 KB |
| 160 |
Nano Carrier Entrapped Vitamin D3 Oral Dispersion 60000IU
|
|
490 KB |
| 161 |
PROphylaxis
|
|
347 KB |
| 162 |
(r-hFSH) 900 IU (66.0 μg)/1.5 mL Solution
|
|
657 KB |
| 163 |
Dapagliflozin + Metformin XR versus Metformin XR
|
|
548 KB |
| 164 |
IMM-101
|
|
654 KB |
| 165 |
Anifrolumab
|
|
657 KB |
| 166 |
LXE408
|
|
652 KB |
| 167 |
INO-4800
|
|
685 KB |
| 168 |
Amantadine Extended Release Tablet 129/193 mg
|
|
446 KB |
| 169 |
IcoSema and Daily Insulin Glargine 100 units/mL
|
|
733 KB |
| 170 |
BI 685509
|
|
655 KB |
| 171 |
LTX-109 3% gel
|
|
323 KB |
| 172 |
Dapagliflozin + Metformin Hydrochloride IP (Extended Release) + Sitagliptin Phosphate monohydrate IP eq. to Sitagliptin film coated bilayered tablets (Phase III)
|
|
331 KB |
| 173 |
MEDI3506
|
|
667 KB |
| 174 |
Anti-HIV microbicide gel
|
|
2139 KB |
| 175 |
Alpelisib plus Fulvestrant
|
|
2590 KB |
| 176 |
OMS721
|
|
675 KB |
| 177 |
Mupirocin 2% w/w Ointment
|
|
428 KB |
| 178 |
remibrutinib LOU064
|
|
675 KB |
| 179 |
Dato-DXd
|
|
782 KB |
| 180 |
Metformin Hydrochloride IP (as prolonged release) + Teneligliptin IP + Dapagliflozin tablets (Phase III)
|
|
190 KB |
| 181 |
COVID-19 (Adapt Out COVID)
|
|
748 KB |
| 182 |
Paclitaxel-Carboplatin-Oregovomab)
|
|
655 KB |
| 183 |
Trastuzumab Deruxtecanas
|
|
771 KB |
| 184 |
Mirabegron (As extended release) + Silodosin film coated bilayered tablets (Phase III)
|
|
184 KB |
| 185 |
Bempedoic acid
|
|
24271 KB |
| 186 |
Darolutamide
|
|
2994 KB |
| 187 |
Lemborexant
|
|
23275 KB |
| 188 |
Sitagliptin Phosphate monohydrate IP eq. to Sitagliptin + Dapagliflozin tablets (Phase III)
|
|
258 KB |
| 189 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Glimepiride IP + Metformin Hydrochloride IP tablets (Phase III)
|
|
247 KB |
| 190 |
Ozenoxacin Lotion 2% w/v
|
|
1196 KB |
| 191 |
CKD-314
|
|
689 KB |
| 192 |
Esmprazole Dual release Gastro Resistant Tablets 80 mg
|
|
515 KB |
| 193 |
Adjuvant Giredestrant
|
|
739 KB |
| 194 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Sitagliptin Phosphate monohydrate IP eq. Sitagliptin + Metformin Hydrochloride IP Film coated tablet (Phase III)
|
|
234 KB |
| 195 |
brequinar combined dipyridamole
|
|
657 KB |
| 196 |
Metoprolol Succinate IP (ER) + Azelnidipine IP film coated bilayered tablets (Phase III)
|
|
184 KB |
| 197 |
Bilastine + Montelukast sodium IP eq. to Montelukast IP per 5ml oral suspension (Phase III)
|
|
168 KB |
| 198 |
Plecanatide
|
|
23335 KB |
| 199 |
remibrutinib (LOU064)
|
|
671 KB |
| 200 |
Cariprazine
|
|
2129 KB |
| 201 |
IMU-838 versus Placebo
|
|
656 KB |
| 202 |
IMU-838
|
|
657 KB |
| 203 |
Peptide Receptor Radionuclide Therapy (PRRT)
|
|
765 KB |
| 204 |
dabrafenib plus trametinib
|
|
660 KB |
| 205 |
asciminib
|
|
656 KB |
| 206 |
INTP24 Against Avastin®
|
|
661 KB |
| 207 |
cccc
|
|
2368 KB |
| 208 |
Amivantamab and Lazertinib
|
|
668 KB |
| 209 |
Teneligliptin IP + Rosuvastatin Calcium IP tablets (Phase III)
|
|
253 KB |
| 210 |
Dapagliflozin + Vildagliptin tablets (Phase III)
|
|
198 KB |
| 211 |
triptyline IP + Methylcobalamin IP + Pregabalin IP (SR) Tablets (Phase III)
|
|
231 KB |
| 212 |
Trastuzumab Deruxtecan (T-DXd)
|
|
521 KB |
| 213 |
Tirzepatiden
|
|
680 KB |
| 214 |
inclisiran
|
|
439 KB |
| 215 |
LIB003 in Heterozygous
|
|
659 KB |
| 216 |
Alcaftadine Nasal Spray CT NOC
|
|
404 KB |
| 217 |
Alcaftadine Nasal Spray ALDP001
|
|
389 KB |
| 218 |
Lastacaft
|
|
389 KB |
| 219 |
Alcaftadine Nasal Spray
|
|
400 KB |
| 220 |
CSJ117
|
|
653 KB |
| 221 |
Rilematovir (JNJ-53718678)
|
|
505 KB |
| 222 |
MSP008-22c
|
|
2128 KB |
| 223 |
Bisoprolol Fumarate IP + Telmisartan IP uncoated bilayered tablets (Phase III)
|
|
172 KB |
| 224 |
Zinc Citrate Trihydrate eq. to Zinc IP +Ascorbic Acid IP effervescent tablets (Phase IV)
|
|
187 KB |
| 225 |
LIB003n
|
|
650 KB |
| 226 |
LIB003 (Low density lipoprotein)
|
|
650 KB |
| 227 |
Itolizumab
|
|
670 KB |
| 228 |
Marstacimab Prophylaxis
|
|
645 KB |
| 229 |
antiviral therapies
|
|
4141 KB |
| 230 |
Capmatinib film coated tablet 150 mg/200 mg
|
|
2260 KB |
| 231 |
Pharmacokinetics of Remdesivir
|
|
2831 KB |
| 232 |
Brazikumabn
|
|
665 KB |
| 233 |
ADG20
|
|
514 KB |
| 234 |
INO-4800
|
|
673 KB |
| 235 |
Proxalutamide (GT0918
|
|
518 KB |
| 236 |
Brazikumab
|
|
666 KB |
| 237 |
Finerenone
|
|
508 KB |
| 238 |
Deupirfenidone (LYT-100)
|
|
501 KB |
| 239 |
Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin + Glimepiride IP + Metformin Hydrochloride IP (as extended release) Film coated bilayered tablets (Phase III)
|
|
245 KB |
| 240 |
NNC0194-0499
|
|
529 KB |
| 241 |
OAV101
|
|
496 KB |
| 242 |
Letrozole Tablet 5 mg
|
|
2846 KB |
| 243 |
Brinzolamide IP + Brimonidine Tartrate IP Ophthalmic suspension (Phase III)
|
|
184 KB |
| 244 |
Urosodiol Injection 625 mg/25ml 925mg/ml)
|
|
3072 KB |
| 245 |
Study (NEST)
|
|
652 KB |
| 246 |
MYL-1701P
|
|
510 KB |
| 247 |
Intravitreal OPT-302
|
|
338 KB |
| 248 |
Remdesivir for injection 100mg/vial
|
|
2819 KB |
| 249 |
Loeglitazone sulphate 0.5 mg tablets
|
|
2617 KB |
| 250 |
Ad26.COV2.S
|
|
664 KB |
| 251 |
PF-07321332/Ritonavir
|
|
410 KB |
| 252 |
OPT-302
|
|
672 KB |
| 253 |
HRF-10071
|
|
2295 KB |
| 254 |
Vilanterol Trifenatate eq. to Vilanterol + Fluticasone Furoate per actuation delivers metered dose inhalation (Phase III)
|
|
224 KB |
| 255 |
PDP-1 17
|
|
2303 KB |
| 256 |
ziltivekimab1
|
|
646 KB |
| 257 |
MRG-001,
|
|
646 KB |
| 258 |
ISTH0036
|
|
476 KB |
| 259 |
FP-025
|
|
483 KB |
| 260 |
Gadoteridol 279.3mg/ml Injection
|
|
2210 KB |
| 261 |
Nortriptyline IP + Methylcobalamin IP + Pregabalin IP (SR) Film Coated Tablets (Phase III)
|
|
203 KB |
| 262 |
Anti-COVID-19 AKS-452 vaccine
|
|
671 KB |
| 263 |
Acalabrutinibz
|
|
967 KB |
| 264 |
Naltrexone Hydrochloride + Zonisamide sustained release capsules (Phase II)
|
|
242 KB |
| 265 |
Teneligliptin Hydrobromide IP + Dapagliflozin tablets (Phase III)
|
|
131 KB |
| 266 |
Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin
|
|
502 KB |
| 267 |
Varespladib-Methyl
|
|
650 KB |
| 268 |
Angiotensin Receptor Blocker (ARB)
|
|
651 KB |
| 269 |
Imetelstat (GRN163L)
|
|
514 KB |
| 270 |
Favipiravir Tablet 200/800 m
|
|
675 KB |
| 271 |
Apremilast Topcial Gel 2%
|
|
3225 KB |
| 272 |
Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IP + Glimepiride IP tablets (Phase III)
|
|
230 KB |
| 273 |
Betamethasone dipropionate Ph. Eur + Calcipotriol anhydrous Ph. Eur. Cutaneous spray (Phase III)
|
|
220 KB |
| 274 |
BP01 (Bevacizumab)
|
|
656 KB |
| 275 |
Polatuzumab Vedotin
|
|
649 KB |
| 276 |
unadjuvanted RSV Maternal vaccine
|
|
657 KB |
| 277 |
Bisoprolol IP + Telmisartan IP tablets (Phase III)
|
|
208 KB |
| 278 |
Bempedoic acid 180 mg tabletct
|
|
239 KB |
| 279 |
Secukinumab
|
|
654 KB |
| 280 |
Azelnidipine + Telmisartan IP tablets (Phase III)
|
|
215 KB |
| 281 |
Inhaled Ampion
|
|
668 KB |
| 282 |
Bempedoic acid 180 mg tablet
|
|
2853 KB |
| 283 |
Silodosin + Tadalafil capsules (Phase III)
|
|
287 KB |
| 284 |
Saroglitazar Tablet 4 mg
|
|
2782 KB |
| 285 |
Bilastine + Montelukast Sodium IP eq. to Montelukast oral suspension (Phase III)
|
|
197 KB |
| 286 |
Tirzepatide
|
|
660 KB |
| 287 |
Sitagliptin Phosphate IP eq. to Sitagliptin + Pioglitazone Hydrochloride IP eq. to Pioglitazone IP + Metformin Hydrochloride IP(as sustained release) tablets (Phase III)
|
|
233 KB |
| 288 |
Hydroxyprogesterone Caproate Intramuscular Injection
|
|
651 KB |
| 289 |
Iptacopan (LNP023)
|
|
651 KB |
| 290 |
Dapagliflozin + Teneligliptin Hydrobromide Hydrate IP Phase III)
|
|
192 KB |
| 291 |
Indacaterol Maleate eq. to Indacaterol + Budesonide IP per actuation delivers metered dose inhaler (Phase III)
|
|
197 KB |
| 292 |
Pioglitazone Hydrochloride IP + Teneligliptin Hydrobromide Hydrate IP tablets (Phase III)
|
|
185 KB |
| 293 |
Indacaterol Maleate eq. to Indacaterol + Budesonide IP dry powder for inhalation (capsules) (Phase III)
|
|
207 KB |
| 294 |
Fesoteroduine Fumarate Extend release tabklet 4 mg/8 mg and Solifenacin sucinate tablets 5 mg/10 mg
|
|
2540 KB |
| 295 |
Typhoid Conjugate
|
|
567 KB |
| 296 |
Fimasartan Potassium + Chlorthalidone IP tablets (Phase III)
|
|
176 KB |
| 297 |
BP05 Versus EU-Approved Lucentis®
|
|
674 KB |
| 298 |
ziltivekimab
|
|
446 KB |
| 299 |
Cetrelimab
|
|
689 KB |
| 300 |
Nucleocapsid
|
|
326 KB |
| 301 |
Acalabrutinib
|
|
404 KB |
| 302 |
SARS-CoV-2Vaccine
|
|
323 KB |
| 303 |
Favipiravir Tablet 200/400/800 mg
|
|
2852 KB |
| 304 |
(KAE609)
|
|
653 KB |
| 305 |
Ozenoxacin Lotion 2% W/v
|
|
3467 KB |
| 306 |
Favipiravir tablet 200 mg/400 mg/800 mg
|
|
2836 KB |
| 307 |
Efonidipine hydrochloride Ethanolate + Telmisartan IP Film coated bilayered tablet (Phase III)
|
|
215 KB |
| 308 |
Amoxicillin Trihydrate 759.04 mg eq. to Amoxicillin free acid 652.78 mg* + Potassium Clavulanate 61.48 mg eq. to Clavulanic acid 50.41mg
|
|
176 KB |
| 309 |
Remdesivir 100 mgb
|
|
2180 KB |
| 310 |
Tapentadol Hydrochloride Nasal Spray 225 mg/ml
|
|
3553 KB |
| 311 |
Cipargamin
|
|
543 KB |
| 312 |
Atacicept
|
|
659 KB |
| 313 |
PTG-300
|
|
2593 KB |
| 314 |
Lenvatinib 4/10 mg Capsule
|
|
3239 KB |
| 315 |
HGCO19
|
|
313 KB |
| 316 |
SARS-CoV-2V
|
|
669 KB |
| 317 |
Favipiravir tablet 400 mg
|
|
2337 KB |
| 318 |
Vildagliptin SR + Metformin Hydrochloride (SR) uncoated bilayered tablets (Phase III)
|
|
199 KB |
| 319 |
Teneligliptin Hydrobromide hydrate eq. to Teneligliptin + Dapagliflozin tablets (Phase III)
|
|
170 KB |
| 320 |
Sitagliptin Phosphate IP eq. to Sitagliptin + Dapagliflozin tablets (Phase III)
|
|
182 KB |
| 321 |
Favipiravir tablet 800 mg
|
|
2285 KB |
| 322 |
Remdesivir 100 mgh
|
|
2560 KB |
| 323 |
Talazoparib With Enzalutamide
|
|
654 KB |
| 324 |
LNP023n
|
|
649 KB |
| 325 |
Cocculus hirsutus
|
|
3037 KB |
| 326 |
Remdesivir 100 mgj
|
|
2305 KB |
| 327 |
Remdesivir 100 mgc
|
|
2484 KB |
| 328 |
Metformin hydrochloride IP (as an extended-release form) + Sitagliptin Phosphate IP eq. to Sitagliptin + Dapagliflozin tablets (Phase III)
|
|
216 KB |
| 329 |
Mifepristone 10/25 mg Tablet
|
|
2861 KB |
| 330 |
Rilematovir
|
|
409 KB |
| 331 |
Sputnik Light
|
|
229 KB |
| 332 |
BBV154
|
|
423 KB |
| 333 |
C21
|
|
409 KB |
| 334 |
Remdesivir for Injection 100mg/ml
|
|
2877 KB |
| 335 |
Remdesivir for Injection 100mg/ml
|
|
3135 KB |
| 336 |
Favipiravir tablet 200 mgw
|
|
2590 KB |
| 337 |
Teneligliptin hydrobromide hydrate eq to Teneligliptin IP + Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin film coated tablets (Phase III)
|
|
236 KB |
| 338 |
Semaglutide 2.4 mg
|
|
406 KB |
| 339 |
2-Deoxy-D-Glucose Oral Powder 2.34 gm & 3.0 gm
|
|
176 KB |
| 340 |
Doxazosin Tablet 2 mg
|
|
2638 KB |
| 341 |
Chimpanzee Adenovirus Vectored
|
|
276 KB |
| 342 |
COVAXIN
|
|
308 KB |
| 343 |
Atezolizumab
|
|
680 KB |
| 344 |
Remdesivir 100 mg
|
|
2480 KB |
| 345 |
Encorafenib Plus Cetuximab
|
|
657 KB |
| 346 |
Favipiravirtablet 200 mg
|
|
2341 KB |
| 347 |
Lidocaine Spray 10% w/v
|
|
175 KB |
| 348 |
Remdesivir100 mg
|
|
248 KB |
| 349 |
Favipiravir tablet 200 mgf
|
|
2341 KB |
| 350 |
Favipiravir tablet 200 mg
|
|
2181 KB |
| 351 |
Favipiravir tablet 200 mgdr
|
|
2181 KB |
| 352 |
VIB7734
|
|
655 KB |
| 353 |
EQ001
|
|
639 KB |
| 354 |
Olaparib
|
|
501 KB |
| 355 |
Niclosamidee
|
|
496 KB |
| 356 |
Duloxetine (as delayed release pellets) IP + Pregabalin IP hard gelatin capsules (Phase III)
|
|
217 KB |
| 357 |
ensovibep (MP0420)
|
|
530 KB |
| 358 |
Insulin Degludec 100 units/mL
|
|
410 KB |
| 359 |
Aspirin (EC) IP + Ticagrelor (SR) IP capsules (Phase III)
|
|
199 KB |
| 360 |
Levonadifloxacinw
|
|
2474 KB |
| 361 |
Levonadifloxacinn
|
|
2474 KB |
| 362 |
RP7214
|
|
2293 KB |
| 363 |
Azilsartan Medoxomil + Amlodipine tablets (Phase III)
|
|
286 KB |
| 364 |
Vildagliptin SR + Metformin Hydrochloride SR IP Sustained release tablets (Phase III)
|
|
192 KB |
| 365 |
Endoxifen
|
|
2385 KB |
| 366 |
RP7214jss
|
|
2693 KB |
| 367 |
CA-170
|
|
2252 KB |
| 368 |
Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP
|
|
405 KB |
| 369 |
imatinib mesylate
|
|
458 KB |
| 370 |
PF-07321332
|
|
506 KB |
| 371 |
Amikacin Sulphate
|
|
386 KB |
| 372 |
LIB003
|
|
498 KB |
| 373 |
Endoxifen2
|
|
2358 KB |
| 374 |
Minocycline Hydrochloride Topical Gel 4%
|
|
2674 KB |
| 375 |
Atropine Sulfate Ophthalmic Solution USP 0.01% w/v
|
|
706 KB |
| 376 |
LY3471851
|
|
638 KB |
| 377 |
C-TB with QuantiFERON-TB Gold Plus and 2.T.U. Tuberculin PPD RT23
|
|
2167 KB |
| 378 |
VPM1002 (rBCG) Vaccine
|
|
223 KB |
| 379 |
23-valent Pneumococcal Polysaccharide Vaccine I.P.
|
|
388 KB |
| 380 |
Lifitegrast
|
|
2347 KB |
| 381 |
Dextromethorphan Polistirex eq. to Dextromethorphan Hydrobromide IP + Chlorpheniramine Polistirex eq. to Chlorpheniramine Maleate + Methylparaben IP + Propylparaben IP per 5ml sustained release oral suspension (Phase IV)
|
|
222 KB |
| 382 |
Nitric oxide
|
|
2443 KB |
| 383 |
EMPAgliflozin
|
|
537 KB |
| 384 |
ofatumumab and siponimod versus fingolimod
|
|
501 KB |
| 385 |
Coronavirus vaccine (rDNA) – BBV151
|
|
319 KB |
| 386 |
Dienogest 2mg Tablet
|
|
345 KB |
| 387 |
Aqueous chlorine S
|
|
2399 KB |
| 388 |
Vildagliptin (as sustained release) + Dapagliflozin tablets (Phase III)
|
|
266 KB |
| 389 |
JNJ-42756493
|
|
492 KB |
| 390 |
Urosdexycholic Acid Tablet 150/mg/300 mg
|
|
3327 KB |
| 391 |
Solidarity trial
|
|
3455 KB |
| 392 |
Molnupiravir Mild2
|
|
3954 KB |
| 393 |
Dapagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin + Metformin Hydrochloride IP Film coated tablet (Phase III)
|
|
233 KB |
| 394 |
NNC0365-3769
|
|
404 KB |
| 395 |
Hydrochloroquinee
|
|
187 KB |
| 396 |
OQL011
|
|
503 KB |
| 397 |
Multitope Protein/ Peptide-Based SARS-CoV-2 Vaccine (Manufactured by M/s Aurobindo Pharma Limited, Hyderabad) 2. UB-612(Imported from M/s UBI Pharma (UBIP),Taiwan)
|
|
302 KB |
| 398 |
Metoprolol Succinate eq. to Metoprolol Tartrate IP + Azelnidipine IP tablets (Phase III)
|
|
198 KB |
| 399 |
Erdafitinib
|
|
497 KB |
| 400 |
Flupentixol + Melitracen tablets (Phase IV)
|
|
139 KB |
| 401 |
Montelukast Sodium IP eq. to Montelukast + Bilastine orodispersible tablet (Phase III)
|
|
190 KB |
| 402 |
GRC 17536
|
|
2255 KB |
| 403 |
ODM-203
|
|
2225 KB |
| 404 |
Fluticasone Furoate + Umeclidinium Bromide + Vilanterol Trifenatate powder for inhalation (Phase IV)
|
|
201 KB |
| 405 |
AB1001
|
|
2037 KB |
| 406 |
PNB-001
|
|
2870 KB |
| 407 |
ZYIL 1
|
|
2179 KB |
| 408 |
ZY-19489
|
|
2106 KB |
| 409 |
MKP-10241
|
|
2162 KB |
| 410 |
SARS-CoV-2 Adjuvanted Recombinant
|
|
505 KB |
| 411 |
Duloxetine Hydrochloride eq. to Duloxetine (as gastro resistant pellets) IP + Pregabalin IP Capsules (Phase III)
|
|
215 KB |
| 412 |
Quercetin Nutraceutical bar
|
|
2159 KB |
| 413 |
Anti-COVID19 Serum [Equine Anti Covid Antibody Fragments F(ab’)2]
|
|
292 KB |
| 414 |
Gam-COVID-Vac combined vector vaccine Component Iand Component II
|
|
229 KB |
| 415 |
Molnupiravir Mildapl
|
|
2404 KB |
| 416 |
Molnupiravir Moderateapl
|
|
2472 KB |
| 417 |
Aviptadil2
|
|
2481 KB |
| 418 |
Palbociclib versus Anastrozole
|
|
326 KB |
| 419 |
Bilastine Tablets 40mg
|
|
3789 KB |
| 420 |
Galcanezumab in Adolescent Patients
|
|
640 KB |
| 421 |
Larotrectinib
|
|
392 KB |
| 422 |
Niclosamide
|
|
2820 KB |
| 423 |
Chikungunya vaccine (Inactivated)
|
|
225 KB |
| 424 |
Quadrivalent Influenza Seasonal Vaccine (QIV) (Virus Like Particle)
|
|
294 KB |
| 425 |
Diphtheria and Tetanus Vaccine (Adsorbed) for Adults and Adolescents IP
|
|
86 KB |
| 426 |
Molnupiravir Moderatepure
|
|
3944 KB |
| 427 |
Galcanezumab
|
|
498 KB |
| 428 |
Oral Cholera Vaccine (Inactivated)
|
|
305 KB |
| 429 |
Vildagliptin +Dapagliflozin tablets (Phase III)
|
|
292 KB |
| 430 |
Molnupiravir Mildm1
|
|
1872 KB |
| 431 |
Molnupiravir MildB1
|
|
1709 KB |
| 432 |
Adaptive Platform Treatment Trial
|
|
515 KB |
| 433 |
Molnupiravir Moderatem3
|
|
2003 KB |
| 434 |
Molnupiravir Milds1
|
|
2391 KB |
| 435 |
Recombinant Hepatitis E Vaccine
|
|
788 KB |
| 436 |
Molnupiravir Moderateb2
|
|
1763 KB |
| 437 |
Molnupiravir Mild
|
|
2203 KB |
| 438 |
Molnupiravir Moderate
|
|
3074 KB |
| 439 |
Molnupiravir Milda
|
|
2008 KB |
| 440 |
Molnupiravir Moderaten
|
|
1999 KB |
| 441 |
Molnupiravir Mild1
|
|
2417 KB |
| 442 |
Molnupiravir Moderate2
|
|
2469 KB |
| 443 |
Molnupiravir Mildh
|
|
2557 KB |
| 444 |
Molnupiravir Moderateh2
|
|
2634 KB |
| 445 |
Molnupiravir Mildr
|
|
18881 KB |
| 446 |
Molnupiravir Moderater1
|
|
1955 KB |
| 447 |
Molnupiravir Moderate2s
|
|
2451 KB |
| 448 |
ATR-002
|
|
527 KB |
| 449 |
LNP023 in primary IgA nephropathy
|
|
497 KB |
| 450 |
Whole-Virion Inactivated SARS-CoV-2 Vaccine
|
|
566 KB |
| 451 |
Inactivated Japanese encephalitis vaccine
|
|
566 KB |
| 452 |
Aceclofenac IP + Linceed Oil (containing predominantly-Linolenic acid) + Methyl Salicylate IP + Capsaicin USP +Menthol IP + Benzyl Alcohol IP (as preservative) ointment (Phase III)
|
|
298 KB |
| 453 |
Carboplatin and Paclitaxel
|
|
619KB |
| 454 |
Equine Anti Covid Antibody Fragments F(ab)2
|
|
954 KB |
| 455 |
Trastuzumab and Pertuzumab
|
|
504 KB |
| 456 |
ruxolitinib and panobinostat (LBH589)
|
|
310 KB |
| 457 |
Pamrevlumab
|
|
496 KB |
| 458 |
Benralizumab
|
|
497 KB |
| 459 |
Gam-COVID-Vac combined vector vaccine Component I and Component II)
|
|
442 KB |
| 460 |
Covid-19 vaccine containing Receptor Binding Domain of SARS-CoV-2 (RBD antigen of SARS CoV-2 (Covid-19))
|
|
315 KB |
| 461 |
Sodium Hyaluronate + Polyethylene Glycol 400 + Propylene Glycol lubricant eye drops (Phase IV)
|
|
292 KB |
| 462 |
Tropicamide IP + Phenylephrine Hydrochloride IP + Lidocaine Hydrochloride IP injection (Phase IV)
|
|
300 KB |
| 463 |
Biapenam Injection 300 mg
|
|
2411 KB |
| 464 |
Niclosamide Tablets
|
|
3263 KB |
| 465 |
Dapagliflozin + Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin film coated tablets (Phase III)
|
|
286 KB |
| 466 |
(TACTIC-E)
|
|
497 KB |
| 467 |
Azelnidipine IP Metoprolol Succinate IP eq. to Metoprolol Tartrate (SR) film coated tablets (Phase III)
|
|
283 KB |
| 468 |
osilodrostat (LCI699)
|
|
491 KB |
| 469 |
Liraglutide 3.0 mg
|
|
490 KB |
| 470 |
Vildagliptin + Pioglitazone Hydrochloride IP eq. to Pioglitazone film coated tablets (Phase III)
|
|
304 KB |
| 471 |
Randomized SARS
|
|
2197 KB |
| 472 |
Object Head wise Budget allocation for the year2021-22 under Revenue & Capital Expenditure in respect of CDSCO(HQ
|
|
14497 KB |
| 473 |
AQCH
|
|
2605 KB |
| 474 |
insulin glargine 100 units/m
|
|
503 KB |
| 475 |
SNG001
|
|
507 KB |
| 476 |
Ozenoxacin2
|
|
2351 KB |
| 477 |
Desidustat
|
|
2242 KB |
| 478 |
Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin + Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin film coated tablets (Phase III)
|
|
329 KB |
| 479 |
Sugammadex
|
|
2369 KB |
| 480 |
Aqueous chlorine
|
|
2210 KB |
| 481 |
MSP008-22
|
|
2172 KB |
| 482 |
SAR440340/REGN3500/itepekimab (anti-IL-33 mAb)
|
|
503 KB |
| 483 |
Pneumococcal (Polysaccharide Conjugate Vaccine (15-Valent)
|
|
339 KB |
| 484 |
T4030
|
|
511 KB |
| 485 |
Bilastine tab
|
|
2423 KB |
| 486 |
Vildagliptin + Metformin Hydrochloride IP Film coated bilayered tablets (Phase III)
|
|
322 KB |
| 487 |
Bilastine + Montelukast sodium IP eq. to Montelukast IP per 5ml suspension (Phase III)
|
|
321 KB |
| 488 |
SAR440340/REGN3500/itepekimab
|
|
498 KB |
| 489 |
selexipagn
|
|
360 KB |
| 490 |
Novel Corona Virus Vaccine -2019-nCov Vaccine (3mg dose- 28 days Schedule)
|
|
316 KB |
| 491 |
Budesonide, Glycopyrronium
|
|
326 KB |
| 492 |
Glycopyrrolate IP + Formoterol Fumarate Dihydrate IP eq to Formoterol Fumarate Inhalation Aerosol per actuation deliver (Phase IV)
|
|
215 KB |
| 493 |
fibrinogen concentrate (FIB Grifols)
|
|
316 KB |
| 494 |
Neoadjuvant Osimertinib
|
|
498 KB |
| 495 |
SAR443122
|
|
499 KB |
| 496 |
EdoxabaN foR IntraCranial Hemorrhage
|
|
524 KB |
| 497 |
CT-P42
|
|
519 KB |
| 498 |
RSV Maternal Vaccine
|
|
434 KB |
| 499 |
finerenone
|
|
394 KB |
| 500 |
Tropicamide IP + Phenylephrine Hydrochloride IP + Lidocaine Hydrochloride IP per ml solution for Injection (Phase IV)
|
|
5090 KB |
| 501 |
Pneumococcal (Polysaccharide Conjugate Vaccine (14-Valent)
|
|
327 KB |
| 502 |
Fenebrutinib
|
|
592 KB |
| 503 |
Tapentadol Hy
|
|
5845 KB |
| 504 |
Pregabalin IP (as prolonged release) + Etoricoxib IP uncoated bilayered tablets (Phase IV)
|
|
5808 KB |
| 505 |
Duloxetine Hydrochloride eq. to Duloxetine (as delayed release pellets) + Pregabalin IP Capsules
|
|
291 KB |
| 506 |
Sucroferic oxyhydroxide
|
|
2340 KB |
| 507 |
Ozenoxacin
|
|
2072 KB |
| 508 |
Brazikumab2
|
|
622 KB |
| 509 |
Inebilizumab2
|
|
495 KB |
| 510 |
30 mg bid of evenamide (NW-3509)
|
|
502 KB |
| 511 |
BG00012 and BIIB017
|
|
|
| 512 |
Trastuzumab Deruxtecan (T-DXd, DS-8201a)
|
|
489 KB |
| 513 |
Roxadustat (FG-4592)
|
|
495 KB |
| 514 |
Trastuzumab Deruxtecan
|
|
498 KB |
| 515 |
pasireotide
|
|
495 KB |
| 516 |
Efgartigimod PH20 SC1
|
|
494 KB |
| 517 |
Brazikumab
|
|
623 KB |
| 518 |
Chimpanzee Adenovector Corona Virus Vaccine (BBV152)
|
|
222 KB |
| 519 |
SARS-Cov2-rs Protein recombinant spike protein nanoparticle vaccine
|
|
235 KB |
| 520 |
Semaglutide with alcoholic steatohepatitis
|
|
509 KB |
| 521 |
semaglutide 25 mg compared with 14 mg
|
|
423 KB |
| 522 |
Adapalene EP + Benzoyl Peroxide EP per gram topical Gel (Phase IV)
|
|
323 KB |
| 523 |
Linezolid in combination with Bedaquiline and Pretomanid
|
|
2517 KB |
| 524 |
Colchicine
|
|
2435 KB |
| 525 |
Pregabalin IP (as sustained release tablet) + Duloxetine HCl IP eq to Duloxetine (as enteric coated tablet) hard gelatin capsule (Phase III)
|
|
307 KB |
| 526 |
darolutamide
|
|
321 KB |
| 527 |
Vildagliptin + Metformin Hydrochloride IP Film coated bilayered sustained release tablets (Phase III)
|
|
321 KB |
| 528 |
Hyperimmune Intravenous Immunoglobulin
|
|
493 KB |
| 529 |
Leuprolide Acetatea
|
|
4345 KB |
| 530 |
Marzeptacog alfae
|
|
498 KB |
| 531 |
Durvalumab1
|
|
490 KB |
| 532 |
Aviptadiln
|
|
2393 KB |
| 533 |
Aviptadil
|
|
2363 KB |
| 534 |
M-RNA Vaccine for Injection (Covid-19)
|
|
405 KB |
| 535 |
Equine Covid-19 Antiserum
|
|
290 KB |
| 536 |
Bempedoic acid
|
|
2475 KB |
| 537 |
Levonadifloxacin
|
|
2507 KB |
| 538 |
Tetracosactide
|
|
2087 KB |
| 539 |
Chlorhexidine Gluconate solution + Metronidazole Benzoate BP eq to Metronidazole Gel (Phase III)
|
|
276 KB |
| 540 |
Inosine Pranobex
|
|
2553 KB |
| 541 |
Biapenam injection
|
|
2519 KB |
| 542 |
S007-1500
|
|
2165 KB |
| 543 |
Novel CoronaVirus2019-nCoV Vaccine
|
|
306 KB |
| 544 |
Oral Eflornithine NSRT2020
|
|
2898 KB |
| 545 |
Acalabrutinib
|
|
6492 KB |
| 546 |
Carvedilol _ Ivabradine Hydrochloride eq. to Ivabradine film coated tablets (Phase IV)
|
|
316 KB |
| 547 |
Efgartigimod PH20 SC
|
|
494 KB |
| 548 |
Selexipag
|
|
492 KB |
| 549 |
Taliglucerase Alfa
|
|
492 KB |
| 550 |
Bevacizumab
|
|
316 KB |
| 551 |
JS016
|
|
318 KB |
| 552 |
AMT-101
|
|
503 KB |
| 553 |
Bilastine + Montelukast sodium IP eq. to Montelukast Oral Suspension (Phase III
|
|
318 KB |
| 554 |
Mirabegron (ER) + Solifenacin Succinate IP tablets (Phase III
|
|
297 KB |
| 555 |
Levobupivacaine Hydrochloride eq. to Levobupivacaine + Dextrose liquid injection (Phase III)
|
|
321 KB |
| 556 |
Pregabalin (as sustained release) IP + Methylcobalamin IP + Nortriptyline Hydrochloride IP eq. to Nortriptyline IP tablets (Phase III)
|
|
300 KB |
| 557 |
Bepotastine Besilate + Montelukast Sodium IP eq. to Montelukast film coated tablets (Phase III)
|
|
285 KB |
| 558 |
Budesonide + Glycopyrronium + Formoterol Fumarate inhalation Powder (Phase IV)
|
|
304 KB |
| 559 |
noxaparin) in COVID-19
|
|
501 KB |
| 560 |
Metformin HCl (SR) + Myo-Inositol film coated bilayered tablets (Phase III)
|
|
330 KB |
| 561 |
RIVACA
|
|
3602 KB |
| 562 |
Baricitinib
|
|
500 KB |
| 563 |
Potassium Chloride (K-Lyte)
|
|
419 KB |
| 564 |
Brimonidine IP + Brinzolamide IP + Timolol eq. to Timolol Maleate IP + Benzalkonium chloride solution IP (as preservative) + Water for injection IP q.s. per ml Ophthalmic Suspension (Phase III)
|
|
322 KB |
| 565 |
Randomized
|
|
2969 KB |
| 566 |
Alogliptin Benzoate eq. to Alogliptin + Metformin Hydrochloride IP Film Coated Tablet (Phase IV)
|
|
281 KB |
| 567 |
Lidocaine Hydrochloride IP + Diltiazem Hydrochloride IP Gel (Phase III)
|
|
286 KB |
| 568 |
Marzeptacog Alfa
|
|
185 KB |
| 569 |
2-Deoxy-D-glucose
|
|
2313 KB |
| 570 |
Daclatasvir dihydrochloride IP eq. to Daclatasvir + Sofosbuvir film coated tablet with or without Nitazoxanide in combination with standard of care in adult patients with moderate Covid-19 (Phase IIB)
|
|
3097 KB |
| 571 |
AS012
|
|
506 KB |
| 572 |
Pregabalin IP (as prolonged release form) + Mecobalamin IP + Nortriptyline HCl film coated bilayered tablet (Phase III)
|
|
3209 KB |
| 573 |
Pioglitazone IP + Vildagliptin (as sustained release form) Film coated bilayered tablet (Phase III)
|
|
3024 KB |
| 574 |
Amino Acid + Glucose 7.5% with Electrolytes and Vitamin B1 Injection (BFLUID) (1000 ml Bag each) (Phase III)
|
|
4216 KB |
| 575 |
Chikungunya vaccine (Inactivated)
|
|
533 KB |
| 576 |
inebilizumab
|
|
506 KB |
| 577 |
LY3471851
|
|
503 KB |
| 578 |
Mycobacterium w (Heat KilledInjection
|
|
394 KB |
| 579 |
SARS-CoV-2 (Covid-19) Vaccine
|
|
1184 KB |
| 580 |
Saxagliptin + Dapagliflozin Film coated tablets (Phase IV)
|
|
2849 KB |
| 581 |
Durvalumab
|
|
1426 KB |
| 582 |
Ketorolac Tromethamine 30mg
|
|
3039 KB |
| 583 |
Whole Virion, Inactivated Corona Virus Vaccine,BBV152
|
|
1793 KB |
| 584 |
Gam COVID Vac Combined vector vaccine component one and component two
|
|
1928 KB |
| 585 |
Chlorthalidone IP + Fimasartan Potassium Trihydrate eq. to Fimasartan Potassium film coated tablets (Phase III)
|
|
2804 KB |
| 586 |
Insulin Glargine
|
|
518 KB |
| 587 |
Bemcentinib
|
|
440 KB |
| 588 |
Intramuscular Injection of Paracetamol 500 mg/2ml
|
|
2812 KB |
| 589 |
Betamethasone Dipropionate USP + Clotrimazole USP + Gentamicin Sulfate USP Cream (Phase III)
|
|
2397 KB |
| 590 |
SARS-CoV-2 Equine Antiserum Immunoglobulin (Purified F(ab)2 fragment)
|
|
561 KB |
| 591 |
oral Etrasimod
|
|
2964 KB |
| 592 |
Sodium Copper Chlorophyllin
|
|
2955 KB |
| 593 |
M/s Synokem Pharmaceuticals Ltd
|
|
1087 KB |
| 594 |
LIB003 with Evolocumab
|
|
302 KB |
| 595 |
Pantoprazole Sodium IP Aspirin IP Capsules
|
|
664 KB |
| 596 |
Pioglitazone Hydrochloride IP eq. to Pioglitazone + Teneligliptin Hydrochloride Hydrate IP eq. to Teneligliptin tablets (Phase III)
|
|
2943 KB |
| 597 |
Acotiamide Hydrochloride hydrate SR Tablet 300mg
|
|
3185 KB |
| 598 |
Nertrasudil + Latanoprost
|
|
2686 KB |
| 599 |
Iguratimod tablets 25 mg
|
|
12792 KB |
| 600 |
Follicle-Stimulating Hormone and Human Chorionic Gonadotropin
|
|
1997 KB |
| 601 |
Abemaciclib
|
|
1306 KB |
| 602 |
Efonidipine Hydrochloride Ethanolate + Telmisartan IP uncoated bilayered tablets (Phase III)
|
|
2608 KB |
| 603 |
Osimertinib Vs Savolitinib
|
|
494 KB |
| 604 |
Amivantamab & Carboplatin
|
|
494 KB |
| 605 |
SAR442168(Multiple Sclerosis)
|
|
498 KB |
| 606 |
Lasmiditan
|
|
502 KB |
| 607 |
lasmiditan (Migraine)
|
|
502 KB |
| 608 |
oral Etrasimod
|
|
392 KB |
| 609 |
Ticagrelor SR Tablets 120mg/180mg
|
|
3334 KB |
| 610 |
Lumasiran
|
|
1801 KB |
| 611 |
Desidustat
|
|
285 KB |
| 612 |
Metformin Hydrochloride + Doxycycline Hyclate gel (Phase II)
|
|
3020 KB |
| 613 |
Reversible Inhibition of Sperm under Guidance (RISUG)
|
|
227 KB |
| 614 |
Ruxolitinib
|
|
1483 KB |
| 615 |
PNB-001
|
|
10107 KB |
| 616 |
Gepotidacinrevised
|
|
502 KB |
| 617 |
Osimertinib Versus lazertinib
|
|
1456 KB |
| 618 |
Bosutinib tab
|
|
292 KB |
| 619 |
HRF-10071 tab
|
|
226 KB |
| 620 |
Semaglutide (T2diabetes)
|
|
508 KB |
| 621 |
GSK3196165
|
|
535 KB |
| 622 |
Teriflunomide
|
|
414 KB |
| 623 |
Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin + Pioglitazone Hydrochloride eq. to Pioglitazone film coated tablets (Phase III)
|
|
3333 KB |
| 624 |
SAR442168 to Placebo
|
|
500 KB |
| 625 |
Epinephrine Sublingual tab
|
|
202 KB |
| 626 |
2'0 Methyl Antisense Oligonucleotide
|
|
290 KB |
| 627 |
Evenamide
|
|
272 KB |
| 628 |
Capmatinib
|
|
261 KB |
| 629 |
dimethyl Fumarate
|
|
500 KB |
| 630 |
Alpelisib
|
|
264 KB |
| 631 |
SAR442168
|
|
481 KB |
| 632 |
nWhole Virion, Inactivated Corona Virus Vaccine, Whole Virion, Inactivated Corona Virus Vaccine (BBV152D)
|
|
264 KB |
| 633 |
PF-06826647n
|
|
509 KB |
| 634 |
Ligelizumab
|
|
509 KB |
| 635 |
Thymosin a-1 for Injection 1.6mg
|
|
2970 KB |
| 636 |
oral Semaglutide
|
|
505 KB |
| 637 |
Evobrutinib
|
|
403 KB |
| 638 |
Bilastine tablet 40mg
|
|
4275 KB |
| 639 |
Bilastine Tablet 40 mg
|
|
4257 KB |
| 640 |
Adjuvant Durvalumab
|
|
378 KB |
| 641 |
Fluticasone Furoate + Oxymetazoline hydrochloride IP nasal spray (Phase III)
|
|
3016 KB |
| 642 |
C21n
|
|
613 KB |
| 643 |
Typhoid Vi Conjugate Vaccine I.P.n
|
|
295 KB |
| 644 |
Niclosamide IM depot Injection
|
|
2410 KB |
| 645 |
Gemcitabine revised
|
|
775 KB |
| 646 |
Azelnidipine 8 mg plus Metoprolol Succinate ER 50 mg tab and Azelnidipine 16 mg plus Metoprolol Succinate ER 50 mg tab
|
|
13899 KB |
| 647 |
DFV890
|
|
487 KB |
| 648 |
Dapagliflozin
|
|
372 KB |
| 649 |
Otilimab
|
|
325 KB |
| 650 |
Pregabalin IP + Duloxetine Hydrochloride IP eq. to Duloxetine (as gastro resistant pellets) hard gelatin capsules (Phase III)
|
|
3280 KB |
| 651 |
Azelnidipine IP + Olmesartan Medomoxil IP film coated tablet (Phase III)
|
|
2918 KB |
| 652 |
ChAdOx1 nCoV- 19 Corona Virus Vaccine (Recombinant)
|
|
2002 KB |
| 653 |
Trastuzumab Deruxtecan
|
|
491 KB |
| 654 |
Capaivasertib+Abiraterone
|
|
331 KB |
| 655 |
PF-06865571
|
|
377 KB |
| 656 |
TRC041266
|
|
10239 KB |
| 657 |
Mirikizumab
|
|
259 KB |
| 658 |
Inosine Pranobex 500 mg
|
|
11600 KB |
| 659 |
Bepotastine Besilate + Ketorolac Tromethamine IP + Benzalkonium Chloride IP (as preservative) per ml Ophthalmic Solution (Phase III)
|
|
3761 KB |
| 660 |
Desidustat tab
|
|
11490 KB |
| 661 |
PF-06826647
|
|
260 KB |
| 662 |
Secukinumabd
|
|
257 KB |
| 663 |
Netarsudil Ophthalmic sol 0.02%`w/v
|
|
13846 KB |
| 664 |
Erenumab
|
|
497 KB |
| 665 |
Perampanel
|
|
305 KB |
| 666 |
S (-) Metoprolol Succinate IH + Efonidipine Hydrochloride Ethanolate IH modified release uncoated bilayered tablets (Phase III)
|
|
1595 KB |
| 667 |
Pregabalin ER
|
|
194 KB |
| 668 |
Trenexamic Acid
|
|
257 KB |
| 669 |
Typhoid Vi Conjugate Vaccine I.P.
|
|
566 KB |
| 670 |
Typhoid Vi Conjugate Vaccine I.P.1
|
|
566 KB |
| 671 |
Efonidipine Hydrochloride Ethanolate + Chlorthalidone IP uncoated bilayered tablets (Phase III)
|
|
4512 KB |
| 672 |
ct Umifenovir Hcl cap
|
|
1833 KB |
| 673 |
Novel Corona Virus 2019-nCoV Vaccine
|
|
1665 KB |
| 674 |
Gemcitabine
|
|
367 KB |
| 675 |
Fitusiran
|
|
475 KB |
| 676 |
SCD411 And Eylea
|
|
502 KB |
| 677 |
Gepotidacin
|
|
483 KB |
| 678 |
Brolucizumab
|
|
312 KB |
| 679 |
Dacomitinib tab 15 rm
|
|
234 KB |
| 680 |
Lorlatinib tab 25 rmg
|
|
241 KB |
| 681 |
VIB4920
|
|
318 KB |
| 682 |
Somapacitan
|
|
493 KB |
| 683 |
Pirfenidone 267 mg tab
|
|
1675 KB |
| 684 |
Whole Virion, Inactivated Corona Virus Vaccine, Whole Virion, Inactivated Corona Virus Vaccine (BBV152)
|
|
330 KB |
| 685 |
Naftifine Hydrochloride Gel 2%
|
|
232 KB |
| 686 |
Topiroxostat tablets 20 mg/40mg/60 mg
|
|
248 KB |
| 687 |
Dienogest (Ph IV)
|
|
254 KB |
| 688 |
Hydrocorticosone Acetate
|
|
379 KB |
| 689 |
PF-06480605
|
|
377 KB |
| 690 |
Acodiamide Hydrochloride 300 mg
|
|
1873 KB |
| 691 |
Lipoprotein
|
|
674 KB |
| 692 |
C21
|
|
509 KB |
| 693 |
Acalabrutinib
|
|
399 KB |
| 694 |
Umifenovir
|
|
2588 KB |
| 695 |
Sphaeranthus Indicus Extract
|
|
2203 KB |
| 696 |
Measles and Rubella vaccine (Live)
|
|
288 KB |
| 697 |
Diphtheria and Tetanus Vaccine (Adsorbed) for Adults and Adolescents I.P.
|
|
275 KB |
| 698 |
Benidipine Hydrochloride + Chlorthalidone IP Film coated tablets (Phase III)
|
|
273 KB |
| 699 |
Yellow Fever Vaccine (live) I.P.
|
|
220 KB |
| 700 |
Hepcidin Mimetic PTG-300
|
|
496 KB |
| 701 |
BDB001
|
|
236 KB |
| 702 |
Colloidal silver BP 50 ppm
|
|
12437 KB |
| 703 |
IIIM-290
|
|
942 KB |
| 704 |
Azacitidine
|
|
250 KB |
| 705 |
Ulinastatin for Injection
|
|
1431 KB |
| 706 |
Favipiravir & Umifenovir
|
|
12027 KB |
| 707 |
Nafamostat Mesilate for inj
|
|
11361 KB |
| 708 |
ZYBK2
|
|
9991 KB |
| 709 |
2-Deoxy-D-Glucose (2-DG)
|
|
240 KB |
| 710 |
NitazoxanideTablet 500 mgHydroxychloroquine Tablet 200 mg
|
|
1361 KB |
| 711 |
Cocculus hirsutus
|
|
1154 KB |
| 712 |
Favipiravir
|
|
12309 KB |
| 713 |
NitazoxanideTabet 500 mg and Hydroxychloroquine Tablet 200 mg
|
|
1456 KB |
| 714 |
BCG vaccine
|
|
219 KB |
| 715 |
Dutasteride topical
|
|
371 KB |
| 716 |
Dustasteride Topical solution 0.01% w/v, 0.02% w/v and 0.005% w/v
|
|
679 KB |
| 717 |
Sotagliflozin
|
|
534 KB |
| 718 |
PIK3CA
|
|
296 KB |
| 719 |
Favipiravir
|
|
2366 KB |
| 720 |
Mycobacterium w (Heat Killed) Injection2
|
|
235 KB |
| 721 |
Mycobacterium w (Heat Killed) Injection1
|
|
235 KB |
| 722 |
Remdesevir (GS-5734) for inj 100 mg
|
|
1914 KB |
| 723 |
Mycobacterium w (Heat Killed) Injection
|
|
209 KB |
| 724 |
VPM1002(recombinant BCG) vaccine
|
|
207 KB |
| 725 |
S.C. Secukinumab
|
|
360 KB |
| 726 |
Osimertinib
|
|
399 KB |
| 727 |
VIS649
|
|
375 KB |
| 728 |
Concizumab
|
|
497 KB |
| 729 |
CPI-613
|
|
498 KB |
| 730 |
lumasiran
|
|
493 KB |
| 731 |
Fimasartan Potassium Trihydrate eq. to Fimasartan Potassium +Cilnidipine IP Film coated tablets (Phase III)
|
|
309 KB |
| 732 |
Apremilast 60 mg Tablet 60 mg Tablet
|
|
1831 KB |
| 733 |
CA-170
|
|
234 KB |
| 734 |
Zika Virus Vaccine (Adsorbed), Zika Virus Vaccine (Adsorbed)
|
|
221 KB |
| 735 |
5-aminolevulinic Acid
|
|
384 KB |
| 736 |
vaporized cannabinoids
|
|
225 KB |
| 737 |
Acotiamide Sustained 300 mg Tablet 300 mg t
|
|
1819 KB |
| 738 |
Acotiamide Sustained 300 mg Tablet 300 mg Tablet
|
|
2037 KB |
| 739 |
Secukinumab
|
|
497 KB |
| 740 |
Intravenous Secukinimab
|
|
497 KB |
| 741 |
Glycopyrrolate IP eq. to Glycopyrronium + Arformoterol Tartrate eq. to Arformoterol Inhalation solution (Phase III)
|
|
303 KB |
| 742 |
Bilastine + Montelukast Sodium IP eq. to Montelukast Film coated tablets
|
|
288 KB |
| 743 |
Canagliflozin + Metformin HCl Film coated tablets (Phase IV)
|
|
216 KB |
| 744 |
Medroxyprogesterone Acetate SR tablet30 mg 30 mg Tablet
|
|
1570 KB |
| 745 |
Oral Pharmacokinetics and Safety of TRC041266 Powder with TRC4186 Tablet
|
|
195 KB |
| 746 |
DE-109
|
|
258 KB |
| 747 |
Tirzepatide
|
|
518 KB |
| 748 |
M/s Biological E Limited
|
|
572 KB |
| 749 |
Fimasartan Potassium Trihydrate eq. to Fimasartan Potassium + Chlorthalidone IP Film coated tablets (Phase III)
|
|
336 KB |
| 750 |
Cefpodoxime Proxetil 200/400 mgTablet
|
|
2025 KB |
| 751 |
Inactivated Hepatitis A vaccine
|
|
281 KB |
| 752 |
Selpercatinib
|
|
491 KB |
| 753 |
ZYBK2
|
|
206 KB |
| 754 |
zelnidipine 8 mg plus Telmisartan 40 mg and Azelnidipine 16 mg plus Telmisartan 40mg tab versus Azelnidipine tab 16 mg and Telmisartan tab 40 mg
|
|
376 KB |
| 755 |
Cabozantinib or Vandetanib
|
|
419 KB |
| 756 |
Estradiol Valerate 4mg SR Table
|
|
1773 KB |
| 757 |
Pregabalin IP + Duloxetine Hydrochloride IP eq. to Duloxetine (as delayed release pellets) hard gelatin capsules (Phase III)
|
|
248 KB |
| 758 |
Diphtheria, Tetanus, Pertussis (Whole cell), Hepatitis B (rDNA), Haemophilus influenzae Type b Conjugate and Poliomyelitis (Inactivated) Vaccine (Adsorbed)
|
|
308 KB |
| 759 |
Fimasartan Potassium Trihydrate eq. to Fimasartan Potassium + Chlorthalidone IP Film coated tablets (Phase III)
|
|
318 KB |
| 760 |
Evenamide (NW-3509)2
|
|
269 KB |
| 761 |
Evenamide2
|
|
379 KB |
| 762 |
Tirzepatide
|
|
256 KB |
| 763 |
AR-301
|
|
251 KB |
| 764 |
Bedaquiline, Delamanid
|
|
360 KB |
| 765 |
Bedaquiline Tablets 100mg
|
|
255 KB |
| 766 |
Tropifexor (LJN452) & licogliflozin
|
|
429 KB |
| 767 |
Dienogest (Visanne®)
|
|
196 KB |
| 768 |
Typhoid Conjugate Vaccine (Monovalent)
|
|
289 KB |
| 769 |
Hydroxychloroquine Sulfate Tablet 200mg/300 mg
|
|
788 KB |
| 770 |
Hydrocortisone Acetate Suppositories, 25 Mg
|
|
303 KB |
| 771 |
Goserelin 10.8mg Injection1
|
|
1460 KB |
| 772 |
Ipatasertib
|
|
505 KB |
| 773 |
Inactivated Therapeutic Tuberculosis Vaccine.RUTI Vaccine
|
|
185 KB |
| 774 |
Inactivated Therapeutic Tuberculosis Vaccine
|
|
185 KB |
| 775 |
Fingolimod capsule
|
|
2608 KB |
| 776 |
Remogliflozin Etabonate + Teneligliptin Hydrobromide Hydrate IP eq. to Teneligliptin Film coated tablets (Phase III)
|
|
302 KB |
| 777 |
Glimepiride IP + Voglibose IP + Metformin HCl IP (as ER) uncoated bilayered tablet (Phase IV)
|
|
242 KB |
| 778 |
Silodosin + Solifenacin Succinate Ph. Eur. Capsule (Phase III)
|
|
337 KB |
| 779 |
Mirabegron + Solifenacin Succinate tablets (Phase III)
|
|
232 KB |
| 780 |
Ivabradin Tablet
|
|
2543 KB |
| 781 |
sacubitril/valsartan
|
|
251 KB |
| 782 |
Goserelin 10.8mg Injection
|
|
381 KB |
| 783 |
Bilastine + Montelukast Sodium IP eq. to Montelukast uncoated tablet (Phase III)
|
|
297 KB |
| 784 |
Brimonidine Tartrate 0.1% Ophthalmic Solution
|
|
325 KB |
| 785 |
Selonsertib
|
|
1460 KB |
| 786 |
Evenamide(NW-3509/008/II/2019)
|
|
375 KB |
| 787 |
PF-06741086
|
|
493 KB |
| 788 |
Remogliflozin Etabonate Vildagliptin film coated tablet
|
|
1222 KB |
| 789 |
Capmatinib
|
|
249 KB |
| 790 |
Hydrocortisone Acetate
|
|
358 KB |
| 791 |
Ripasudil HCl Hydrate eq. To Ripasudil Timolol Maleate IP Eq. To to Timolol eye drops
|
|
1008 KB |
| 792 |
Cephalexin extended release Clavulanate Potassium tablet
|
|
1016 KB |
| 793 |
Ceftazidime
|
|
321 KB |
| 794 |
Goserelin 3.6 mg Injection
|
|
495 KB |
| 795 |
Triamcinolone acetonide IP Lignocaine HCl IP Gel
|
|
712 KB |
| 796 |
Ceftazidime-Avibactam
|
|
489 KB |
| 797 |
GSK2831781
|
|
502 KB |
| 798 |
Lipidol
|
|
3028 KB |
| 799 |
Gepotidacin
|
|
256 KB |
| 800 |
Evenamide(NW-3509/006/III/2019)
|
|
509 KB |
| 801 |
Evenamide(nw-3509)
|
|
509 KB |
| 802 |
Meningococcal (A, C, Y, W, X) Polysaccharide Conjugate Vaccine (Freeze Dried)
|
|
193 KB |
| 803 |
Prohance® (Gadoteridol 279.3 mg/mllnjection
|
|
2667 KB |
| 804 |
Dalbavancin
|
|
2754 KB |
| 805 |
Azelnidipine Olmesartan Medoxomil IP tablets
|
|
1260 KB |
| 806 |
opivacaine Hydrochloride USP eq. to anhydrous Ropivacaine hydrochloride Dextrose IP per ml injection
|
|
959 KB |
| 807 |
Benidipine HCl Chlorthalidone IPTelmisartan IP Film coated bilayered tablets
|
|
876 KB |
| 808 |
Rosuvastatin IP Teneligliptin Film coated tablet
|
|
1099 KB |
| 809 |
SB3
|
|
249 KB |
| 810 |
International Centre for Genetic Engineering and Biotechnology CampusBivalent (JAIVAC-2: PfMSPFu24 +PfF2/ Alhydrogel) P. falciparum malaria vaccine
|
|
167 KB |
| 811 |
Baricitinib eli lily
|
|
509 KB |
| 812 |
TRUNCATE – TB (tuberculosis)
|
|
3884 KB |
| 813 |
Lenvatinib Capsules 4 mg and 10 mg
|
|
330 KB |
| 814 |
Azilsartan KamedoxomilChlorthalidone IP tablet
|
|
654 KB |
| 815 |
Ticagrelor 120/180 mg SR Tablet
|
|
2652 KB |
| 816 |
Diptheria,Tetanus, Pertussis (Whole cell),Hepatitis B, Poliomyelitis (inactivated) and Haemophilus Influenzae Type b conjugate Vaccine (Adsorbed) [DTwPHepB-IPV-Hib vaccine (Adsorbed
|
|
207 KB |
| 817 |
AUR101
|
|
3310 KB |
| 818 |
AUR101
|
|
3310 KB |
| 819 |
Desidustat Tablet versus Epoetin alfa Injection
|
|
2558 KB |
| 820 |
PNB-001
|
|
267 KB |
| 821 |
Recombinant Hepatitis E Vaccine, Single Human Dose
|
|
266 KB |
| 822 |
Zileuton Ointment 1.25% and 5.0%
|
|
702 KB |
| 823 |
Concizumab Prophylaxis
|
|
508 KB |
| 824 |
Avanafil tablets 100 mg & 200 mg
|
|
1223 KB |
| 825 |
Oral Baricitinib
|
|
503 KB |
| 826 |
Inactivated Hepatitis A Vaccine (Adsorbed) I.P.6nov
|
|
262 KB |
| 827 |
LNP023(Rituximab)
|
|
260 KB |
| 828 |
Iodixanol
|
|
2023 KB |
| 829 |
LNP023
|
|
366 KB |
| 830 |
Concizumab
|
|
327 KB |
| 831 |
Brazikumab
|
|
491 KB |
| 832 |
Etrasimod( IQVIA RDS)
|
|
513 KB |
| 833 |
Etrasimod( IQVIA)
|
|
502 KB |
| 834 |
Etrasimod
|
|
485 KB |
| 835 |
FEIBA
|
|
403 KB |
| 836 |
CT-P13
|
|
471 KB |
| 837 |
Inotuzumab
|
|
370 KB |
| 838 |
Ruxolitinib
|
|
310 KB |
| 839 |
GSK3196165
|
|
284 KB |
| 840 |
Ruxolitinib
|
|
310 KB |
| 841 |
Spironolactone Topical Cream 5%
|
|
1495 KB |
| 842 |
Apremilast Film Coated 10/10/30mg Tablets
|
|
2755 KB |
| 843 |
Tenofovir Alafenamide, Emtricitabine and Bictegravir
|
|
2682 KB |
| 844 |
Sofosbuvir 400 mg Tablet
|
|
2627 KB |
| 845 |
Typhoid Vi conjugate VaccineRa
|
|
276 KB |
| 846 |
Cilnidipine IP Azilsartan Kamedoxomil eq. to Azilsartan Medoxomil tablets
|
|
609 KB |
| 847 |
Benidipine HCl IPTelmisartan IP Film coated tablets
|
|
641 KB |
| 848 |
Azelnidipine Telmisartan tablets
|
|
624 KB |
| 849 |
Methylcobalamin Nasal spray 500 mcg
|
|
284 KB |
| 850 |
Typhoid Vi conjugate Vaccine30sep
|
|
185 KB |
| 851 |
Certican / Zortress(everolimus EVR)
|
|
312 KB |
| 852 |
Tirzepatide1
|
|
313 KB |
| 853 |
Tirzepatide
|
|
313 KB |
| 854 |
QL1205 Versus Lucentis
|
|
304 KB |
| 855 |
Bupivacaine Hydrochloride IP eq. to anhydrous Bupivacaine Hydrochloride Fentanyl Citrate IP Eq. to Fentanyl injection
|
|
672 KB |
| 856 |
AT-10 (2-oxoclopidogrel bisulfate
|
|
2845 KB |
| 857 |
HP-hMG and Menopur®
|
|
2143 KB |
| 858 |
Inactivated Hepatitis A vaccine (Adsorbed) I.P.
|
|
187 KB |
| 859 |
Brazikumab
|
|
393 KB |
| 860 |
Rabies Vaccine, Human, I.P.
|
|
187 KB |
| 861 |
Ribociclib plus goserelin acetate
|
|
434 KB |
| 862 |
Meningococcal Conjugate Vaccine
|
|
510 KB |
| 863 |
semaglutide versus placebo
|
|
477 KB |
| 864 |
evenamide or placebo
|
|
273 KB |
| 865 |
Leuprolide acetate
|
|
2291 KB |
| 866 |
Netarsudil Ophthalmic solution 0.02%
|
|
3055 KB |
| 867 |
MYL-1701P and Eylea
|
|
299 KB |
| 868 |
ligelizumab (QGE031)
|
|
328 KB |
| 869 |
Montelukast sodium eq. to Montelukast IP + Bilastine film coated tablet (Phase III Clinical Trial)
|
|
710 KB |
| 870 |
Montelukast sodium eq. to Montelukast IP + Bilastine film coated tablet (Phase III Clinical Trial)
|
|
710 KB |
| 871 |
Montelukast sodium eq. to Montelukast IP + Bilastine film coated tablet (Phase III Clinical Trial)
|
|
710 KB |
| 872 |
Efonidipine Hydrochloride Ethanolate + Telmisartan IP + Chlorthalidone IP Tablets (Phase III Clinical Trial
|
|
705 KB |
| 873 |
Fimasartan Potassium Trihydrate eq. to Fimasartan Potassium + Cilnidipine IP film coated tablet (Phase III Clinical Trial)
|
|
697 KB |
| 874 |
Mirikizumab
|
|
625 KB |
| 875 |
Menopausal Gonadotropin
|
|
2618 KB |
| 876 |
Azelnidipine IP + Chlorthalidone IP Uncoated Tablet (Phase III Clinical Trial)
|
|
617 KB |
| 877 |
Tranexamic acid
|
|
1667 KB |
| 878 |
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) (10-Valent)
|
|
259 KB |
| 879 |
k0706
|
|
592 KB |
| 880 |
baloxavir marboxil
|
|
492 KB |
| 881 |
Semaglutide
|
|
2366 KB |
| 882 |
traconazole
|
|
1373 KB |
| 883 |
Semaglutide (SOUL)
|
|
2366 KB |
| 884 |
Mirikizumab (UC)
|
|
625 KB |
| 885 |
Filgotinib
|
|
591 KB |
| 886 |
Filgotinib (rheumatoid Arthritis)
|
|
519 KB |
| 887 |
Fluticasone Propionate + Salmeterol inhalation Powder (Phase III Clinical Trial)
|
|
531 KB |
| 888 |
Fluticasone Propionate + Salmeterol inhalation Powder (Phase III Clinical Trial)
|
|
531 KB |
| 889 |
Tigilanol Tiglate
|
|
368 KB |
| 890 |
Capivasertib + Paclitaxel versus placebo
|
|
228 KB |
| 891 |
Baricitinib
|
|
500 KB |
| 892 |
HD204 to Avastin®
|
|
513 KB |
| 893 |
Baricitinib
|
|
500 KB |
| 894 |
Oral Baricitinib
|
|
316 KB |
| 895 |
Evenamide
|
|
608 KB |
| 896 |
Beclomethasone
|
|
1765 KB |
| 897 |
Aceclofenac Topical ointment 1.5% w/wIII
|
|
2285 KB |
| 898 |
Evenamide
|
|
608 KB |
| 899 |
Ulipristal acetate tablet 30mgIII
|
|
2555 KB |
| 900 |
IVIEW-1201
|
|
264 KB |
| 901 |
Sertaconazole Nitrate + Terbinafine HCl cream (Phase III Clinical Trial)
|
|
643 KB |
| 902 |
Ribiciclib
|
|
289 KB |
| 903 |
INTP24 against Avastin® in
|
|
468 KB |
| 904 |
PMZ-1620
|
|
320 KB |
| 905 |
PMZ-1620
|
|
320 KB |
| 906 |
Benidipine Hydrochloride JP + Chlorthalidone IP Film coated tablets (Phase III Clinical Trial
|
|
580 KB |
| 907 |
Benidipine Hydrochloride + Metoprolol Succinate eq. to Metoprolol tartrate IP Film coated tablet (Phase III Clinical Trial)
|
|
357 KB |
| 908 |
Adenosine IP + Minoxidil IP Topical solution (Phase II Clinical Trial)
|
|
626 KB |
| 909 |
Lenalidomide
|
|
267 KB |
| 910 |
AS012
|
|
230 KB |
| 911 |
Osimertinib in Combination with Savolitinib
|
|
492 KB |
| 912 |
Crizanlizumab
|
|
303 KB |
| 913 |
Saroglitazar tablet 4mg II
|
|
2058 KB |
| 914 |
Biapenem 300 mg inj
|
|
368 KB |
| 915 |
Sulbactam-ETX2514
|
|
427 KB |
| 916 |
Rifapentine plus Isoniazid
|
|
259 KB |
| 917 |
IQVIA
|
|
213 KB |
| 918 |
Acotiamide ER tablet 300 tabletIII
|
|
2090 KB |
| 919 |
Ropivacaine Readyfusor 2mg/mlIII
|
|
2629 KB |
| 920 |
Toujeo 300 Units/ml
|
|
486 KB |
| 921 |
Recombinant Hepatitis E Vaccine
|
|
155 KB |
| 922 |
Oral Galactose
|
|
252 KB |
| 923 |
Vi-capsular Polysaccharide-CRM197 Conjugate Typhoid Vaccine
|
|
284 KB |
| 924 |
Guselkumab
|
|
566 KB |
| 925 |
Semaglutide (NN9535-4352)
|
|
429 KB |
| 926 |
Semaglutide
|
|
429 KB |
| 927 |
Curcumin (Biocurcumax cap) as an adjunct drug to standard therapy [(Artesunate) + (Sulfadoxine-Pyrimethamine) tablet]
|
|
238 KB |
| 928 |
2Ó-Methyl-Phosphorothioate Anti Sense Oligoribonucleotide for treating patients with Duchenne Muscular Dystrophy
|
|
231 KB |
| 929 |
Pneumococcal polysaccharide conjugate vaccine (14-valent)
|
|
283 KB |
| 930 |
Typhoid Vi Conjugate Vaccine
|
|
280 KB |
| 931 |
Xlucane versus Lucentis®
|
|
443 KB |
| 932 |
Neoadjuvant/adjuvantDurvalumab
|
|
427 KB |
| 933 |
Durvalumab
|
|
427 KB |
| 934 |
Rituximab Biosimilar (DRL_RI) with MabThera®
|
|
434 KB |
| 935 |
Phenobarbital Sodium Injection
|
|
191 KB |
| 936 |
Tirzepatide
|
|
432 KB |
| 937 |
Baricitinib
|
|
194 KB |
| 938 |
METREXASSIST™
|
|
194 KB |
| 939 |
FDC of Daclatasvir Dihydrochloride Eq. to Daclatasvir 60mg Sofosbuvir 400mg film coated tablets (Phase IV)
|
|
1031 KB |
| 940 |
C.O.M.B.A.T
|
|
222 KB |
| 941 |
Saroglitazar 2mg & 4mg Tablet
|
|
2767 KB |
| 942 |
esidustat vs Darbepoetin
|
|
295 KB |
| 943 |
Sodium Fusidate eq. To Fusidic acid 2% w/w (Sofinox gel)
|
|
3105 KB |
| 944 |
Olaparib
|
|
250 KB |
| 945 |
Tacrolimus lipid tablet 3mg
|
|
2677 KB |
| 946 |
Rivaroxaban tablets 2.5mg (Xarelto®)
|
|
2579 KB |
| 947 |
TRC160334
|
|
295 KB |
| 948 |
Oral Nafithromycin vs oral Moxifloxacin
|
|
417 KB |
| 949 |
Typhoid Conjugate vaccineApril11
|
|
301 KB |
| 950 |
Fitusira
|
|
419 KB |
| 951 |
SB12 and Soliris
|
|
202 KB |
| 952 |
Galcanezumab
|
|
327 KB |
| 953 |
Durvalumab
|
|
208 KB |
| 954 |
SAR341402 Mix 70/30 to NovoMix®3
|
|
337 KB |
| 955 |
Norditropin®
|
|
427 KB |
| 956 |
Lasmiditan
|
|
334 KB |
| 957 |
Typhoid Conjugate vaccine
|
|
301 KB |
| 958 |
Typhoid Conjugate vaccineTCV
|
|
299 KB |
| 959 |
Pharmacokinetic and Pharmacodynamic
|
|
476 KB |
| 960 |
Pharmacokinetics of Murepavadin
|
|
248 KB |
| 961 |
IMU-131 HER2/neu
|
|
427 KB |
| 962 |
Ipatasertib in Combination with Paclitaxel
|
|
194 KB |
| 963 |
Inactivated Japanese Encephalitis Vaccine
|
|
451 KB |
| 964 |
Inactivated poliomyelitis vaccine 12March
|
|
149 KB |
| 965 |
10-valent Pneumococcal Conjugate Vaccine
|
|
322 KB |
| 966 |
Bedaquiline, Delamanid, Linezolid and Clofazimine
|
|
267 KB |
| 967 |
Cetilistat
|
|
394 KB |
| 968 |
Octenidine Dihydrochloride
|
|
318 KB |
| 969 |
Bibrocathol 2% Eye ointment
|
|
303 KB |
| 970 |
Probiotic Supplementation lactic acid bacteria and Bifidobacteria, namely, L. Plantarum DSM24730, L. paracasei DSM 24733, L. delbrueckii subsp. Bulgaricus DSM 24734, L. acidophilus DSM24735, B. longam, DSM24736, B. Infantis DSM 24737, B. breve DSM 24732, and S. thermophilus DSM 24731 which is to be reconstituted with MCT oil drop with Medium Chain Triglyceride (MCT) oil
|
|
2042 KB |
| 971 |
Norethisterone CR tablet 15mg
|
|
2068 KB |
| 972 |
Teneligliptin and Sitagliptin
|
|
247 KB |
| 973 |
secukinumab SUNSHINE
|
|
570 KB |
| 974 |
Edoxaban tosylate
|
|
220 KB |
| 975 |
iGlarLixi versus premixed
|
|
321 KB |
| 976 |
Secukinumab SUNRISE
|
|
570 KB |
| 977 |
Durvalumab in combination
|
|
423 KB |
| 978 |
Inactivated poliomyelitis vaccine
|
|
488 KB |
| 979 |
Liquid ROTAVAC 5CM (Live Attenuated Rotavirus Vaccine)
|
|
277 KB |
| 980 |
Azilsartan Kamedoxomil eq. to Azilsartan Medoxomil Cilnidipine film coated bilayaered tablet (Phase III)
|
|
1652 KB |
| 981 |
Alfuzosin Hydrochloride IP (extended release form) Tadalafil IP film coated tablets (Phase III)
|
|
1141 KB |
| 982 |
Evaluation of Vitamin D Supplementation in affecting the outcome of newly Diagnosed patients with Lymphoma
|
|
217 KB |
| 983 |
Oxaceprol tablet 600mg
|
|
1358 KB |
| 984 |
Tacrolimus lipid suspension 4mg/vial
|
|
1294 KB |
| 985 |
Baricitinib SLE
|
|
581 KB |
| 986 |
Ofatumumab toterability
|
|
195 KB |
| 987 |
Beclomethasone Dipropionate
|
|
581 KB |
| 988 |
Ivermectin Lotion,0.5%
|
|
223 KB |
| 989 |
Durvalumab Monotherapy
|
|
355 KB |
| 990 |
Bepotastine besilate JP Montelukast Sodium IP tablets (Phase III)
|
|
1067 KB |
| 991 |
Phase 3 Relamorelin
|
|
413 KB |
| 992 |
15-Valent Pneumococcal Conjugate Vaccine (PCV15)
|
|
322 KB |
| 993 |
Measles and Rubella Vaccine (Live)
|
|
320 KB |
| 994 |
Rotavirus Vaccine
|
|
321 KB |
| 995 |
Benidipine Hydrochloride IP Telmisartan IP Film coated tablets (Phase III)
|
|
1695 KB |
| 996 |
JHL1101
|
|
498 KB |
| 997 |
efficacy ART-123
|
|
439 KB |
| 998 |
Relamorelin gastroparesis
|
|
238 KB |
| 999 |
Mirabegron (in extended release) Solifenacin Succinate Film coated bilayered tablets (Phase III)
|
|
1117 KB |
| 1000 |
SHP640
|
|
196 KB |
| 1001 |
Teriflunomide tab 14 mg
|
|
428 KB |
| 1002 |
PNB028
|
|
266 KB |
| 1003 |
HRF-4467
|
|
228 KB |
| 1004 |
Durvalumab plus Olaparib
|
|
1481 KB |
| 1005 |
Itraconazole
|
|
1378 KB |
| 1006 |
Prednisone delayed Release Tablet 5 mg
|
|
2670 KB |
| 1007 |
Enbrel®’ (Etanercept
|
|
1379 KB |
| 1008 |
Durvalumab as Consolidation therapy
|
|
1497 KB |
| 1009 |
Relamorelin
|
|
1680 KB |
| 1010 |
Dexamethasone Sodium Phosphate
|
|
1600 KB |
| 1011 |
Single dose Del Nido vs multi dose StThomas II Cardioplegia
|
|
235 KB |
| 1012 |
CPL-2009-0031 tablet 140 mg
|
|
277 KB |
| 1013 |
PMZ-2010
|
|
283 KB |
| 1014 |
Azacitidine
|
|
239 KB |
| 1015 |
CPL-2009-0031 tablet 140 mg of Cadila Pharmaceutical Ltd
|
|
222 KB |
| 1016 |
Durvalumab
|
|
1405 KB |
| 1017 |
Pembrolizumab
|
|
1412 KB |
| 1018 |
LNP3794 in apatients
|
|
1411 KB |
| 1019 |
Crizanlizumab
|
|
1410 KB |
| 1020 |
Dupilumab
|
|
1781 KB |
| 1021 |
Ifetroban
|
|
1415 KB |
| 1022 |
Ivabradine Tablets
|
|
2291 KB |
| 1023 |
Herceptin® or TX05
|
|
1438 KB |
| 1024 |
CT-P16
|
|
1586 KB |
| 1025 |
TX05
|
|
1595 KB |
| 1026 |
Semaglutide
|
|
1601KB |
| 1027 |
Ligelizumab (QGE031)
|
|
1614 KB |
| 1028 |
Cefepime-Tazobactam vs. Meropenem
|
|
1484 KB |
| 1029 |
ligelizumab (QGE031)
|
|
1696 KB |
| 1030 |
ZS (sodium zirconium cyclosilicate
|
|
1636 KB |
| 1031 |
Selinexor (KPT-330
|
|
1592 KB |
| 1032 |
tropifexor (LJN452) and cenicriviroc (CVC)
|
|
1460 KB |
| 1033 |
PXL01
|
|
1568 KB |
| 1034 |
NexoBrid
|
|
1513 KB |
| 1035 |
Coversin
|
|
1489 KB |
| 1036 |
Adapalene and Benzoyl Peroxide Gel, 0.3%/2.5%
|
|
1449 KB |
| 1037 |
Aztreonam-Avibactam (Atm-Avi)
|
|
1491 KB |
| 1038 |
Azacitidine 100 mg
|
|
280 KB |
| 1039 |
Epinephrine plus Vasopressin
|
|
226KB |
| 1040 |
Azelnidipine tab 8 mg / 16 mg
|
|
287 KB |
| 1041 |
Saroglitazar Magnesium
|
|
17176 KN |
| 1042 |
VELPANAT
|
|
197 KB |
| 1043 |
Azelnidipine
|
|
371 KB |
| 1044 |
FDC of Efonidipine Hydrochloride Ethanolate + Metoprolol Succinate IP (as extended release) (20 mg+25mg & 20mg+50mg) Film coated tablets.
|
|
17177 KB |
| 1045 |
Doxycycline
|
|
225 KB |
| 1046 |
Pregabalin
|
|
212 KB |
| 1047 |
Bedaquiline, Delamanid, Linezolid and Clofazimine
|
|
218 KB |
| 1048 |
Tulobuterol Transdermal
|
|
239 KB |
| 1049 |
Enterogermina
|
|
179 KB |
| 1050 |
Desidustat ZYAN1
|
|
236 KB |
| 1051 |
PMZ-1620
|
|
259 KB |
| 1052 |
Nexagon® (NEXAGON)
|
|
1530 KB |
| 1053 |
Tapentadol nasal spray 225mg/ml
|
|
966 KB |
| 1054 |
Semaglutide
|
|
1637 KB |
| 1055 |
Granexin Gel
|
|
545 KB |
| 1056 |
Edoxaban
|
|
1794 KB |
| 1057 |
EG12014
|
|
1782 KB |
| 1058 |
Mirikizumab
|
|
1786 KB |
| 1059 |
LCZ696
|
|
1762 KB |
| 1060 |
Ticagrelor
|
|
1672 KB |
| 1061 |
5-aminolevulinic acid hydrochloride
|
|
1845 KB |
| 1062 |
Brolucizumab
|
|
1822 KB |
| 1063 |
Aztreonam-Avibactam (ATM-AVI Pfizer
|
|
2029 KB |
| 1064 |
Nitazoxanide 500 mg Tablets
|
|
1696 KB |
| 1065 |
KAF156
|
|
1902 KB |
| 1066 |
Efpeglenatide
|
|
444 KB |
| 1067 |
Mirikizumab
|
|
1850 KB |
| 1068 |
Osilodrostat (LCI699
|
|
1794 KB |
| 1069 |
Esmolol Hydrochloride 14.00% w/w topical gel
|
|
1298 KB |
| 1070 |
FDC of Daclatasvir dihydrochloride eq to Daclatasvir 60mg + Sofosbuvir 400mg film coated tablets
|
|
1246 KB |
| 1071 |
Clostridium Botulinum Type-A Toxin Haemagglutinin complex injection 300 units
|
|
1737 KB |
| 1072 |
Dalfampridine
|
|
124 KB |
| 1073 |
Osimertinib
|
|
1773 KB |
| 1074 |
Apremilast Tablets 10/20/30mg Phase IV .
|
|
1708 KB |
| 1075 |
FDC of Metoprolol Succinate ER + Cilnidipine +Telmisartan (25mg + 10mg + 40mg & 50mg + 10mg + 40mg) Tablets
|
|
1300 KB |
| 1076 |
FDC of Metoprolol Tartrate IP + Ivabradine HCL eq to Ivabradine (25mg+5mg & 50mg+5mg) Film coated tablets
|
|
1316 KB |
| 1077 |
Mirikizumab
|
|
1850 KB |
| 1078 |
LCZ696
|
|
1762 KB |
| 1079 |
EG12014
|
|
1782 KB |
| 1080 |
Mirikizumab
|
|
1786 KB |
| 1081 |
Edoxaban
|
|
1794 KB |
| 1082 |
Osilodrostat (LCI699
|
|
1794 KB |
| 1083 |
Paracetamol Injection 500mg/2ml for IM route Phase III
|
|
1960 KB |
| 1084 |
Pilot study on Paracetamol Injection for IM route Pilot study
|
|
1593 KB |
| 1085 |
Bilastine 20 mg
|
|
312 KB |
| 1086 |
Magnesium sulfate
|
|
116 KB |
| 1087 |
Dolutegravir (Phase IV)
|
|
78.6 KB |
| 1088 |
TRC041266
|
|
195 KB |
| 1089 |
KAF156
|
|
1902 KB |
| 1090 |
Scrub Typhus INTREST
|
|
1820 KB |
| 1091 |
Granexin Gel
|
|
545 KB |
| 1092 |
Ticagrelor
|
|
1672 KB |
| 1093 |
5-aminolevulinic acid hydrochloride
|
|
1854 KB |
| 1094 |
Brolucizumab
|
|
1822 KB |
| 1095 |
Aztreonam-Avibactam (ATM-AVI
|
|
2029 KB |
| 1096 |
Nitazoxanide 500 mg Tablets
|
|
1696 KB |
| 1097 |
Tagrisso (Osimertinib)
|
|
137 KB |
| 1098 |
Kyprolis (Carfilzomib)
|
|
184 KB |
| 1099 |
Sodium Copper Chlorophyllin
|
|
155 KB |
| 1100 |
Pregabalin IP (As Prolonged Release) 75mg + Etoricoxib IP 60mg uncoated bilayered tablets (Phase-III).
|
|
1,195 KB |
| 1101 |
Metoprolol Succinate ER + Chlorthalidone + Telmisartan (50mg+12.5mg+40mg, 25mg+12.5mg+40mg)film coated tablets (Phase-III)
|
|
1,027 KB |
| 1102 |
Efonidipine Hydrochloride Ethanolate 20mg + Telmisartan IP 40mg film coated Tablets (Phase-III)
|
|
1,008 KB |
| 1103 |
Alcaftadine 0.25% w/v + Ketoroloc Tromethamine 0.4% w/v Eye drops (Phase-III).
|
|
1,163 KB |
| 1104 |
Azilsartan Medoxomil + Chlorthalidone (40mg+25mg,40mg+12.5mg 40mg+6.25mg) Tablets (Phase-III).
|
|
1,118 KB |
| 1105 |
Tadalafil + Dapoxetine (20mg +60mg, 20mg+30mg, 10mg+30mg) film coated tablets (Phase-III).
|
|
949 KB |
| 1106 |
Sotagliflozin
|
|
1,910 KB |
| 1107 |
Durvalumab
|
|
260 KB |
| 1108 |
Efpeglenatide
|
|
444 KB |
| 1109 |
Filgotinib
|
|
1,786 KB |
| 1110 |
emaglutide 2.4 mg CT/18/000019
|
|
1,708 KB |
| 1111 |
Semaglutide 2.4 mg
|
|
1,722 KB |
| 1112 |
Semaglutide 2.4 mg
|
|
1,708 KB |
| 1113 |
Cinacalcet Hydrochloride
|
|
1,710 KB |
| 1114 |
Enzalutamide
|
|
98.6 KB |
| 1115 |
Delamanid
|
|
82 KB |
| 1116 |
Desidustat
|
|
106 KB |
| 1117 |
Azelnidipine tab 16 mg
|
|
130 KB |
| 1118 |
Calcipotriol/AKVANO 50 µg/g cutaneous solution
|
|
1,737,836 KB |
| 1119 |
Efpeglenatide
|
|
444 KB |
| 1120 |
Permission for conducting a Phase rB/IlA 'clinical study entitled , "A Phase IS /IrA, multi-center , open-label clinical trial to evaluate the safety, to lerability and pharmacokinetic of Desidustat for the patients with Chronic Kidney Disease (CKD) on Dialysis "
|
|
97KB |
| 1121 |
Permission for conducting A Phase 3 clinical trial titled "ATLAS- INH: A Phase 3 Study to Evaluate the Efficacy and Safety of Fitusiran in Patients With Hemophilia A or B, With Inhibitory Antibodies to Factor VIII or IX
|
|
143KB |
| 1122 |
Permission for conducting a clinical study entitled "A Phase-l/ll open label, single arm study to evaluate the pharmacokinetic, safety and tolerability of Delamanid in combination with optimized Multidrug Background Regimen (OBR) for multidrug-Resistant Tuberculosis (MDRTB) in HIV infected and HIV-uninfected children with MDR-TB"
|
|
76KB |
| 1123 |
Permission for conducting a clinical study entitle d, "A multicentric , Randomized , double blind , parallel group, comparative, Phase 3 clinical study to evaluate the efficacy, Safety and Tolerability of Azelnidipine Tablets 16 mg verus Amlodipine Tablets 10 mg in subjects with essential hypertension "
|
|
128KB |
| 1124 |
Ivermectin topical lotion 0.5% w/w
|
|
1,858,593 KB |
| 1125 |
Darunavir Tablet 800mg
|
|
143KB |
| 1126 |
Erdafitinib
|
|
1803 KB |
| 1127 |
Permission for conducting a clinical study entitled , "A multicenter Phase-4 , Open-label, Single-arm, Safety and Efficacy Study of Enzalutarnide in Indian Patients with Progressive Metastatic Castration -Resistant Prostate Cancer (mCRPC) Previously Treated with Docetaxel-Based Chemotherapy"
|
|
105KB |
| 1128 |
Canakinumab
|
|
1877 KB |
| 1129 |
Rigosertib
|
|
1688 KB |
| 1130 |
Paliperidone Palmitate
|
|
1757 KB |
| 1131 |
Atezolizumab
|
|
1769 KB |
| 1132 |
Fitusiran
|
|
1875 KB |
| 1133 |
SCY 078
|
|
242KB |
| 1134 |
Exenatide
|
|
373KB |
| 1135 |
AMG 334
|
|
392KB |
| 1136 |
Baricitinib
|
|
300KB |
| 1137 |
YLB113
|
|
299KB |
| 1138 |
Torsemide Extended Release
|
|
568KB |
| 1139 |
QAW039
|
|
570KB |
| 1140 |
Rilpivirine
|
|
577KB |
| 1141 |
Baricitinib
|
|
300KB |
| 1142 |
MB02 (Bevacizumab Biosimilar Drug)
|
|
573KB |
| 1143 |
NexoBrid
|
|
302KB |
| 1144 |
Emicizumab
|
|
371KB |
| 1145 |
CLS-TA
|
|
1814 KB |
| 1146 |
Fitusiran
|
|
1758 KB |
| 1147 |
Pimodivir15
|
|
1640 KB |
| 1148 |
Pimodivir
|
|
1718 KB |
| 1149 |
ASN100
|
|
1753 KB |
| 1150 |
MEDI-551
|
|
1763 KB |
| 1151 |
Regorafenib
|
|
140KB |
| 1152 |
Fluticasone Propionate 100 mcg and Salmeterol 50 mcg
|
|
1750 KB |
| 1153 |
QVM149
|
|
1804 KB |
| 1154 |
Lenvatinib
|
|
143KB |
| 1155 |
Sofosbuvir / Velpatasvir FDC
|
|
100KB |
| 1156 |
Februric (Febuxostat)
|
|
103KB |
| 1157 |
Pirfenidone
|
|
100KB |
| 1158 |
Anagliptin
|
|
162KB |
| 1159 |
Verapamil ER
|
|
193KB |
| 1160 |
Heptral
|
|
105KB |
| 1161 |
Spironolactone cream 5%
|
|
926KB |
| 1162 |
Heptral
|
|
105kb |
| 1163 |
BIO-11006
|
|
565 KB |
| 1164 |
LUBT010
|
|
371 KB |
| 1165 |
Ataluren
|
|
269 KB |
| 1166 |
ribociclib with endocrine
|
|
423 KB |
| 1167 |
Selinexor (KPT-330)
|
|
445 KB |
| 1168 |
ABP 798
|
|
340 KB |
| 1169 |
Nintedanib Systemic Sclerosis
|
|
404 KB |
| 1170 |
Lorlatinib (PF-06463922)
|
|
470 KB |
| 1171 |
Povidone-Iodine Nail Solution
|
|
103 KB |
| 1172 |
Dapagliflozin 5 and 10 mg
|
|
447 KB |
| 1173 |
Dinutuximab and Irinotecan
|
|
456 KB |
| 1174 |
Canagliflozin in Children
|
|
439 KB |
| 1175 |
SB11
|
|
282 KB |
| 1176 |
Atezolizumab compared with chemotherapy
|
|
109 KB |
| 1177 |
Denosumab
|
|
320 KB |
| 1178 |
CLS-TA Sapphire
|
|
100 KB |
| 1179 |
Selinexor
|
|
448 KB |
| 1180 |
Bempedoic Acid (ETC-1002)
|
|
582 KB |
| 1181 |
LJN452
|
|
367 KB |
| 1182 |
Atezolizumab(ANTI-PD-L1Antibody)
|
|
907 KB |
| 1183 |
Deferasirox Formulation(Granules)
|
|
842 KB |
| 1184 |
Ticagrlor
|
|
1115 KB |
| 1185 |
Ruxolitinib
|
|
849 KB |
| 1186 |
LCZ696 on NT Pro BNP
|
|
1117 KB |
| 1187 |
QAW039 sept
|
|
1132 KB |
| 1188 |
Alpelisib
|
|
861 KB |
| 1189 |
Ixekizumab
|
|
1165 KB |
| 1190 |
PEGylated factor
|
|
1154 KB |
| 1191 |
Abemaciclib
|
|
1210 KB |
| 1192 |
Apixaban
|
|
1104 KB |
| 1193 |
RSV
|
|
868 KB |
| 1194 |
Empagliflozin 10mg
|
|
1138 KB |
| 1195 |
Empagliflozin
|
|
1228 KB |
| 1196 |
LY900014 (Insulin Lispro)
|
|
1115 KB |
| 1197 |
Dapagliflozin PC D1699C00001
|
|
1064 KB |
| 1198 |
LNP1892
|
|
1018 KB |
| 1199 |
MOD-4023
|
|
1274 KB |
| 1200 |
Dulaglutide
|
|
985 KB |
| 1201 |
ovidone -Iodine
|
|
1133 KB |
| 1202 |
Ribociclib
|
|
846 KB |
| 1203 |
ANF-Rho
|
|
1125 KB |
| 1204 |
QMF149 150-80 microgram
|
|
1039 KB |
| 1205 |
SPI-2012
|
|
876 KB |
| 1206 |
Safety Study of Atezolizumab
|
|
814 KB |
| 1207 |
Eltrombopag
|
|
867 KB |
| 1208 |
SAIT101 vs Rituximab
|
|
1353 KB |
| 1209 |
Canagliflozin
|
|
1121 KB |
| 1210 |
Filgotinib Crohn
|
|
1203 KB |
| 1211 |
Filgotinib combined phase
|
|
1008 KB |
| 1212 |
LNP3794
|
|
819 KB |
| 1213 |
sFilgotinib
|
|
1171 KB |
| 1214 |
Secukinumab
|
|
888 KB |
| 1215 |
Filgotinib Rheumatoid
|
|
842 KB |
| 1216 |
Filgotinib Administered
|
|
196 KB |
| 1217 |
LY900014
|
|
1048 KB |
| 1218 |
Tenofovir Alafenamide
|
|
1111 KB |
| 1219 |
Filgotinib
|
|
198 KB |
| 1220 |
Dapagliflozin
|
|
1168 KB |
| 1221 |
CLS-TA
|
|
59 KB |
| 1222 |
Pemafibrate
|
|
1356 KB |
| 1223 |
Filgotinib safety
|
|
1238 KB |
| 1224 |
Selonsertib NASH
|
|
1326 KB |
| 1225 |
Selonsertib
|
|
1320 KB |
| 1226 |
Masitinib vs Placebo
|
|
807 KB |
| 1227 |
Ribociclib LEE011
|
|
831 KB |
| 1228 |
Bedaquiline
|
|
152 KB |
| 1229 |
aprodustat
|
|
227 KB |
| 1230 |
Daprodustat
|
|
183 KB |
| 1231 |
Oral Semaglutide versus
|
|
192 KB |
| 1232 |
LCZ696
|
|
145 KB |
| 1233 |
SAIT101
|
|
148 KB |
| 1234 |
Alphanate®
|
|
139 KB |
| 1235 |
TK-112690
|
|
172 KB |
| 1236 |
Ofatumumab safety
|
|
186 KB |
| 1237 |
Etrolizumab PhaseII/III
|
|
204 KB |
| 1238 |
Pradaxa Capsules
|
|
155 KB |
| 1239 |
Ofatumumab
|
|
188 KB |
| 1240 |
Etrolizumab
|
|
207 KB |
| 1241 |
Clindamycin phosphate
|
|
178 KB |
| 1242 |
DE-117
|
|
200 KB |
| 1243 |
Lixisenatide
|
|
204 KB |
| 1244 |
QVA149
|
|
294 KB |
| 1245 |
Aclidinium
|
|
229 KB |
| 1246 |
Nintedanib oral
|
|
197 KB |
| 1247 |
Sarizotan
|
|
142 KB |
| 1248 |
FIASP
|
|
143 KB |
| 1249 |
Avelumab
|
|
150 KB |
| 1250 |
LY2835219
|
|
295 KB |
| 1251 |
Insulin Degludec
|
|
156 KB |
| 1252 |
Palbociclib
|
|
178 KB |
| 1253 |
CBT124
|
|
222 KB |
| 1254 |
Guidance for global access of OCTAMS
|
|
1,138kb |
| 1255 |
Report Book
|
|
5,165kb |
| 1256 |
Manual of OCTAMS
|
|
4,561kb |
| 1257 |
Guidance Document for Export NOC
|
|
137kb |
| 1258 |
Guidance document for Functions and Responsibilities of Zonal, Sub-zonal & port offices of CDSCO
|
|
4,818kb |
| 1259 |
Sofosbuvir Velpatasvir
|
|
158 KB |
| 1260 |
Cardiovascular safety of Oral Semaglutide
|
|
216 KB |
| 1261 |
MYL-14020
|
|
280 KB |
| 1262 |
Vedolizumab IV
|
|
152 KB |
| 1263 |
Budesonide
|
|
150 KB |
| 1264 |
Dexamethasone sodium
|
|
141 KB |
| 1265 |
Pegylated Interferon @-2a
|
|
143 KB |
| 1266 |
NC0195-0092
|
|
130 KB |
| 1267 |
BCD-055
|
|
148 KB |
| 1268 |
Liraglutide
|
|
136 KB |
| 1269 |
QAW039
|
|
128 KB |
| 1270 |
Oral Semaglutide
|
|
133 KB |
| 1271 |
GS-5745
|
|
138 KB |
| 1272 |
RFB002
|
|
135 KB |
| 1273 |
Semaglutide IGlar SGT2i
|
|
160 KB |
| 1274 |
Trimcinolone Acetonide
|
|
173 KB |
| 1275 |
Rivaroxaban
|
|
148 KB |
| 1276 |
MEDI4736 aug
|
|
211 KB |
| 1277 |
Ceritinib
|
|
144 KB |
| 1278 |
MEDI4736
|
|
189 KB |
| 1279 |
INC280
|
|
2112 KB |
| 1280 |
Ticagrelor
|
|
158 KB |
| 1281 |
QMF149
|
|
225 KB |
| 1282 |
Indacaterol
|
|
277 KB |
| 1283 |
BIASP-30
|
|
198 KB |
| 1284 |
NW-3509A
|
|
153 KB |
| 1285 |
Insulin Aspart
|
|
195 KB |
| 1286 |
MDR-TB Drugs
|
|
151 KB |
| 1287 |
Lopinavir/Ritonavir
|
|
144 KB |
| 1288 |
Insulin degludec may
|
|
216 KB |
| 1289 |
Sofosbuvir
|
|
143 KB |
| 1290 |
B1695502
|
|
225 KB |
| 1291 |
RLX030
|
|
190 KB |
| 1292 |
Clindamycin
|
|
189 KB |
| 1293 |
Semaglutide 2016
|
|
256 KB |
| 1294 |
Masitinib
|
|
178 KB |
| 1295 |
Carbetocin RTS
|
|
1542 KB |
| 1296 |
YLB113
|
|
184 KB |
| 1297 |
Insulin degludec
|
|
245 KB |
| 1298 |
BYL719
|
|
189 KB |
| 1299 |
LEE011
|
|
183 KB |
| 1300 |
Nintedanib
|
|
204 KB |
| 1301 |
Pregabali
|
|
182 KB |
| 1302 |
Bevacizumab
|
|
181 KB |
| 1303 |
Pregabalin
|
|
182 KB |
| 1304 |
Recruitment Rule of Drugs Inspector in CDSCO
|
|
2,512kb |
| 1305 |
Alirocumab
|
|
191 KB |
| 1306 |
CT P10
|
|
186 KB |
| 1307 |
QGE031 CQGE031B2201
|
|
166 KB |
| 1308 |
QGE031 S.c
|
|
191 KB |
| 1309 |
FG-3019s
|
|
190 KB |
| 1310 |
Roxadustat
|
|
187 KB |
| 1311 |
Roxadustat Anemia
|
|
190 KB |
| 1312 |
GENA-05
|
|
160 KB |
| 1313 |
Subcutaneous Secukinumab
|
|
221 KB |
| 1314 |
Dydrogesterone
|
|
178 KB |
| 1315 |
Pregabalin as adjunctive
|
|
171 KB |
| 1316 |
Linaclotide
|
|
225 KB |
| 1317 |
LCZ696 NYHA
|
|
204 KB |
| 1318 |
LCZ696 Paradigm
|
|
235 KB |
| 1319 |
Moroctocog alfa
|
|
166 KB |
| 1320 |
RanibizumAB
|
|
173 KB |
| 1321 |
Canagloflozin
|
|
209 KB |
| 1322 |
Steroids in Iga
|
|
181 KB |
| 1323 |
Insulin Aspart BIAsp
|
|
201 KB |
| 1324 |
Salmeterol
|
|
193 KB |
| 1325 |
Masitinib Lymphoma
|
|
189 KB |
| 1326 |
LEE011 NSAI
|
|
182 KB |
| 1327 |
Amended Checklist for test License Applications Effective From 15 June2011
|
|
69kb |
| 1328 |
Checklist for Test License Appli8cations Effective From 15 June 2011
|
|
143kb |
| 1329 |
Guidance Document on Grant of Licenses in Form 11(Test License)
|
|
618kb |
| 1330 |
Octafibrin
|
|
170 KB |
| 1331 |
DE-109
|
|
180 KB |
| 1332 |
ACTG 5288
|
|
170 KB |
| 1333 |
Dabigatran etexilate dual
|
|
239 KB |
| 1334 |
Clindamycin 1%
|
|
215 KB |
| 1335 |
Bococizumab PF-04950615)
|
|
368 KB |
| 1336 |
Bococizumab
|
|
369 KB |
| 1337 |
LEE011 with Lerozole
|
|
184 KB |
| 1338 |
Masitinib
|
|
210 KB |
| 1339 |
Masitinib Folfiri
|
|
209 KB |
| 1340 |
Rituximab
|
|
190 KB |
| 1341 |
Dabigatran Etexilate
|
|
255 KB |
| 1342 |
Dabigatran
|
|
197 KB |
| 1343 |
Fibrinogen
|
|
182 KB |
| 1344 |
Chemotherapy
|
|
178 KB |
| 1345 |
2 PARALLEL Masitinib
|
|
213 KB |
| 1346 |
Chemoradiation
|
|
162 KB |
| 1347 |
Ticagelor
|
|
189 KB |
| 1348 |
QGE031
|
|
183 KB |
| 1349 |
Isoniazid
|
|
172 KB |
| 1350 |
Tiotropium
|
|
265 KB |
| 1351 |
Labetalol
|
|
162 KB |
| 1352 |
Nifedipine Daga
|
|
165 KB |
| 1353 |
Nifedipine Daga
|
|
165 KB |
| 1354 |
DS-5565
|
|
178 KB |
| 1355 |
Insulin Detemir
|
|
181 KB |
| 1356 |
LY2963019
|
|
200 KB |
| 1357 |
NNC0195-0092
|
|
188 KB |
| 1358 |
Pasireotidestudy
|
|
171 KB |
| 1359 |
Mifepristone
|
|
160 KB |
| 1360 |
Mifepristone and Misoprotol
|
|
163 KB |
| 1361 |
LCI699
|
|
173 KB |
| 1362 |
Pasireotide
|
|
173 KB |
| 1363 |
Policy Initiatives Planned for 2015
|
|
85kb |
| 1364 |
Antidepressant
|
|
149 KB |
| 1365 |
Semaglutide 2014
|
|
198 KB |
| 1366 |
LY2605541
|
|
200 KB |
| 1367 |
Octafibrin GCT/64/14
|
|
197 KB |
| 1368 |
Alglucosidase Alfa
|
|
164 KB |
| 1369 |
Dabigatran BI 655075
|
|
223 KB |
| 1370 |
Ranibizumab VEGF
|
|
180 KB |
| 1371 |
Ranibizumab Brilliance
|
|
191 KB |
| 1372 |
Ranibizumab CRVO
|
|
180 KB |
| 1373 |
Trastuzumab
|
|
216 KB |
| 1374 |
Rituximab RTXM83
|
|
185 KB |
| 1375 |
Afatinib BiBW 2992
|
|
189 KB |
| 1376 |
Afatinib for Patients
|
|
172 KB |
| 1377 |
Alglucosidase
|
|
171 KB |
| 1378 |
Herpes Zoster
|
|
169 KB |
| 1379 |
Pregabalin Adjunctive
|
|
188 KB |
| 1380 |
Paclitaxel
|
|
178 KB |
| 1381 |
Eravacycline
|
|
197 KB |
| 1382 |
Dapagliflozin 10mg
|
|
201 KB |
| 1383 |
UT-15C Phase III
|
|
189 KB |
| 1384 |
UT-15C
|
|
176 KB |
| 1385 |
Bevacizumab AVASTIN
|
|
178 KB |
| 1386 |
Pasireotide LAR
|
|
163 KB |
| 1387 |
LDK378
|
|
219 KB |
| 1388 |
Pertuzumab
|
|
180 KB |
| 1389 |
Ifetroban Injection
|
|
192 KB |
| 1390 |
FactorVIII
|
|
122 KB |
| 1391 |
Baricitinib in Patients
|
|
222 KB |
| 1392 |
Adalimumab
|
|
179 KB |
| 1393 |
Cyclosporine
|
|
190 KB |
| 1394 |
Fluocinolone acetonide intravitreal
|
|
174 KB |
| 1395 |
Ranibizumab 0.5 mg
|
|
188 KB |
| 1396 |
Everolimus with reduced calcineurin
|
|
256 KB |
| 1397 |
Fosaprepitant
|
|
191 KB |
| 1398 |
Masitinib
|
|
198 KB |
| 1399 |
Liraglutide Sitagliptin
|
|
181 KB |
| 1400 |
Sitagliptin
|
|
213 KB |
| 1401 |
NOVA22007
|
|
191 KB |
| 1402 |
QAW039 on FEV1
|
|
184 KB |
| 1403 |
Clindamycin benzoyal peroxide
|
|
265 KB |
| 1404 |
BCD-020
|
|
223 KB |
| 1405 |
Pasireotide S.C
|
|
173 KB |
| 1406 |
Ciprodex
|
|
212 KB |
| 1407 |
Daclizumab
|
|
186 KB |
| 1408 |
Enbrel
|
|
194 KB |
| 1409 |
Remicade
|
|
215 KB |
| 1410 |
Exenatide
|
|
174 KB |
| 1411 |
Ceftazidime CAZ AVI
|
|
200 KB |
| 1412 |
Buparlisib
|
|
182 KB |
| 1413 |
BCD-021
|
|
214 KB |
| 1414 |
Insulin Degludec versus insulin glargine
|
|
277 KB |
| 1415 |
Liraglutide versus sulphonylurea
|
|
211 KB |
| 1416 |
BCD-022
|
|
217 KB |
| 1417 |
tolerability of Secukinumab
|
|
176 KB |
| 1418 |
Everolimus RADOO1
|
|
192 KB |
| 1419 |
Everolimus alone
|
|
183 KB |
| 1420 |
Transfer Policy
|
|
421kb |
| 1421 |
SAR236553
|
|
681 KB |
| 1422 |
subcutaneous Secukinumab
|
|
166 KB |
| 1423 |
Afatinib
|
|
225 KB |
| 1424 |
Sofosbuvir plus ribavirin
|
|
291 KB |
| 1425 |
Everolimus
|
|
243 KB |
| 1426 |
Ceftazidime
|
|
283 KB |
| 1427 |
Fluocinolone
|
|
292 KB |
| 1428 |
FLU D-QIV
|
|
278 KB |
| 1429 |
FIAsP 2014
|
|
279 KB |
| 1430 |
FIAsP Insulin
|
|
280 KB |
| 1431 |
Tenofovir Disoproxil
|
|
303 KB |
| 1432 |
Tenofovir Alafenamide TAF
|
|
314 KB |
| 1433 |
olasertib
|
|
289 KB |
| 1434 |
Baricitinib
|
|
357 KB |
| 1435 |
Diclofenac Gel
|
|
370 KB |
| 1436 |
Baricitinib LY3009104
|
|
348 KB |
| 1437 |
TechnologyMG145
|
|
1410 KB |
| 1438 |
BEZ235
|
|
846 KB |
| 1439 |
Producttrastuzumab
|
|
926 KB |
| 1440 |
LAF237
|
|
293 KB |
| 1441 |
Liraglutide sc Injection
|
|
306 KB |
| 1442 |
Fesoterodine
|
|
305 KB |
| 1443 |
Human rh FV III
|
|
301 KB |
| 1444 |
Octefibrin
|
|
290 KB |
| 1445 |
CP-690,550
|
|
296 KB |
| 1446 |
Tenofovir
|
|
342 KB |
| 1447 |
Lixisenatid Subcutaneous
|
|
382 KB |
| 1448 |
ART-123
|
|
303 KB |
| 1449 |
Quotation of rate contract for supply of Photostat Paper (JK Brand) Last date (27 Jul 2012 )
|
|
129kb |
| 1450 |
Re-tendering for Housekeeping and General cleanliness in the CDSCO(HQ), FDA Bhawan, Kotla Road, New Delhi Last Date ( 27 Jul 2012 )
|
|
903kb |
| 1451 |
Extension of Date of Notice Inviting Tender (NIT) Last Date( 27 Jul 2012 )
|
|
370kb |
| 1452 |
Annual Rate Contract for Hiring taxies 1 Last Date( 27 Jul 2012 )
|
|
132kb |
| 1453 |
Annual Rate Contract for Hiring taxies 2 Last Date ( 27 Jul 2012 )
|
|
1,775kb |
| 1454 |
Annual Rate Contract for Hiring taxies 3 Last Date( 27 Jul 2012 )
|
|
162kb |
| 1455 |
Paliperidone Palmitate Prolonged Release Suspension for Injection 25mg/50mg/75mg/100mg and 150mg (Pre-filled Syringes)
|
|
193 KB |
Downloads/Documents & Publications